Annotation Detail for AKT1
Basic Information Top
| Gene Symbol: | AKT1 ( AKT,MGC99656,PKB,PKB-ALPHA,PRKBA,RAC,RAC-ALPHA ) |
|---|---|
| Gene Full Name: | v-akt murine thymoma viral oncogene homolog 1 |
| Band: | 14q32.33 |
| Quick Links | Entrez ID:207; OMIM: 164730; Uniprot ID:AKT1_HUMAN; ENSEMBL ID: ENSG00000142208; HGNC ID: 391 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa04914 | Progesterone-mediated oocyte maturation |
| hsa04920 | Adipocytokine signaling pathway |
| hsa05160 | Hepatitis C |
| hsa04973 | Carbohydrate digestion and absorption |
| hsa04910 | Insulin signaling pathway |
| hsa04012 | ErbB signaling pathway |
| hsa04010 | MAPK signaling pathway |
| hsa04150 | mTOR signaling pathway |
| hsa05142 | Chagas disease |
| hsa05145 | Toxoplasmosis |
| hsa04620 | Toll-like receptor signaling pathway |
| hsa04630 | Jak-STAT signaling pathway |
| hsa04530 | Tight junction |
| hsa04722 | Neurotrophin signaling pathway |
| hsa05211 | Renal cell carcinoma |
| hsa05223 | Non-small cell lung cancer |
| hsa05222 | Small cell lung cancer |
| hsa05221 | Acute myeloid leukemia |
| hsa05220 | Chronic myeloid leukemia |
| hsa05218 | Melanoma |
| hsa05212 | Pancreatic cancer |
| hsa05213 | Endometrial cancer |
| hsa05210 | Colorectal cancer |
| hsa05214 | Glioma |
| hsa05215 | Prostate cancer |
| hsa04510 | Focal adhesion |
| hsa04062 | Chemokine signaling pathway |
| hsa04210 | Apoptosis |
| hsa04370 | VEGF signaling pathway |
| hsa05200 | Pathways in cancer |
| hsa04660 | T cell receptor signaling pathway |
| hsa04662 | B cell receptor signaling pathway |
| hsa04664 | Fc epsilon RI signaling pathway |
| hsa04666 | Fc gamma R-mediated phagocytosis |
| Pathway ID | Pathway Name |
|---|---|
| Signaling by GPCR | |
| Metabolism of nitric oxide | |
| Signalling by NGF | |
| Apoptosis | |
| Regulation of beta-cell development | |
| Hemostasis | |
| Signaling in Immune system | |
| Integrin cell surface interactions |
| Pathway ID | Pathway Name |
|---|---|
| 200035 | S1P3 pathway |
| 200031 | CD40/CD40L signaling |
| 200033 | Signaling events mediated by PTP1B |
| 200038 | Coregulation of Androgen receptor activity |
| 200183 | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 200189 | FGF signaling pathway |
| 200188 | VEGFR3 signaling in lymphatic endothelium |
| 200032 | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 200002 | Regulation of nuclear SMAD2/3 signaling |
| 200003 | Fc-epsilon receptor I signaling in mast cells |
| 200004 | Endothelins |
| 200005 | BCR signaling pathway |
| 200132 | Nephrin/Neph1 signaling in the kidney podocyte |
| 200156 | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 200151 | VEGFR1 specific signals |
| 200012 | Insulin Pathway |
| 200127 | PDGFR-beta signaling pathway |
| 200125 | E-cadherin signaling in keratinocytes |
| 200124 | IL6-mediated signaling events |
| 200080 | mTOR signaling pathway |
| 200083 | CXCR4-mediated signaling events |
| 200084 | IGF1 pathway |
| 200145 | Nongenotropic Androgen signaling |
| 200144 | Signaling events mediated by the Hedgehog family |
| 200069 | Thromboxane A2 receptor signaling |
| 200142 | Retinoic acid receptors-mediated signaling |
| 200062 | TCR signaling in naive CD8+ T cells |
| 200066 | Angiopoietin receptor Tie2-mediated signaling |
| 200067 | FAS (CD95) signaling pathway |
| 200091 | FoxO family signaling |
| 200099 | IL2 signaling events mediated by PI3K |
| 200172 | HIF-1-alpha transcription factor network |
| 200175 | p53 pathway |
| 200073 | FOXA2 and FOXA3 transcription factor networks |
| 200072 | Regulation of Telomerase |
| 200077 | Glucocorticoid receptor regulatory network |
| 200150 | CXCR3-mediated signaling events |
| 200018 | IL4-mediated signaling events |
| 200169 | Class I PI3K signaling events mediated by Akt |
| 200168 | Insulin-mediated glucose transport |
| 200166 | Aurora A signaling |
| 200162 | a6b1 and a6b4 Integrin signaling |
| 200161 | Signaling events mediated by VEGFR1 and VEGFR2 |
| 200011 | LPA receptor mediated events |
| 200147 | Hedgehog signaling events mediated by Gli proteins |
| 200119 | ErbB2/ErbB3 signaling events |
| 200113 | ErbB1 downstream signaling |
| 200110 | IFN-gamma pathway |
| 200109 | Integrins in angiogenesis |
| 200108 | amb2 Integrin signaling |
| 200022 | TCR signaling in naive CD4+ T cells |
| 200100 | Ceramide signaling pathway |
| 200103 | p75(NTR)-mediated signaling |
| 200105 | E-cadherin signaling in the nascent adherens junction |
| 200029 | Plasma membrane estrogen receptor signaling |
| 200051 | Reelin signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| P00053 | T cell activation |
| P04398 | p53 pathway feedback loops 2 |
| P00056 | VEGF signaling pathway |
| P00019 | Endothelin signaling pathway |
| P00033 | Insulin/IGF pathway-protein kinase B signaling cascade |
| P00018 | EGF receptor signaling pathway |
| P00005 | Angiogenesis |
| P00020 | FAS signaling pathway |
| P00029 | Huntington disease |
| P00048 | PI3 kinase pathway |
| P00030 | Hypoxia response via HIF activation |
| P00006 | Apoptosis signaling pathway |
| P00021 | FGF signaling pathway |
| P00059 | p53 pathway |
| P04397 | p53 pathway by glucose deprivation |
| P00036 | Interleukin signaling pathway |
| P00031 | Inflammation mediated by chemokine and cytokine signaling pathway |
| P04393 | Ras Pathway |
| Pathway ID | Pathway Name |
|---|---|
| 500261 | Activation of BAD and translocation to mitochondria |
| 500642 | Negative regulation of the PI3K/AKT network |
| 500641 | AKT phosphorylates targets in the nucleus |
| 500640 | AKT phosphorylates targets in the cytosol |
| 500485 | CD28 dependent PI3K/Akt signaling |
| 500523 | AKT-mediated inactivation of FOXO1A |
| 500639 | PI3K/AKT signalling |
| 500487 | CTLA4 inhibitory signaling |
| 500849 | eNOS activation |
| No data |
| Desease ID | Desease Name |
|---|---|
| 1745 | Huntington disease |
| 1818 | Systemic scleroderma |
| 1856 | Obesity |
| 1904 | Diabetes mellitus |
| 1918 | Atherosclerosis |
| 1934 | Cancer |
| 2036 | Tropical spastic paraparesis |
| 2091 | Hypertension |
| 2040 | Hyperglycemia |
| 2069 | Schizophrenia |
| 2102 | Polycystic ovary syndrome |
| 2111 | Systemic infection |
| 2118 | Adenovirus infection |
| 2123 | Vitiligo |
| 2198 | Psychotic disorder |
| Desease Name |
|---|
| CHEMDEPENDENCY |
| methamphetamine abuse |
| PSYCH |
| schizophrenia |
| No data |
| Desease Name |
|---|
| Schizophrenia, susceptibility to |
| Breast cancer, somatic |
| Ovarian cancer, somatic |
| Colorectal cancer, somatic |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C496879 | 103D5R | 103D5R results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15695405 |
| C046783 | 11,12-epoxy-5,8,14-eicosatrienoic acid | 11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Terfenadine analog results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19289568 |
| C435044 | 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol | 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol results in decreased activity of AKT1 protein | decreases activity | 15691865 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [P2RY1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16236484 |
| C046782 | 14,15-epoxy-5,8,11-eicosatrienoic acid | 14,15-epoxy-5,8,11-eicosatrienoic acid results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16286479 |
| C074153 | 1,4-phenylenebis(methylene)selenocyanate | 1,4-phenylenebis(methylene)selenocyanate results in decreased expression of AKT1 protein | decreases expression | 16399772 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 16611854 |
| C060229 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15800129 |
| C060229 | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C112765 | 17-(allylamino)-17-demethoxygeldanamycin | 17-(allylamino)-17-demethoxygeldanamycin results in decreased expression of AKT1 protein | decreases expression | 17157164 |
| C477931 | 1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate | 1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate results in decreased activity of AKT1 protein | decreases activity | 16178010 |
| C468114 | 1-palmitoyl-2-arachidonyl-3-phosphorylcholine | 1-palmitoyl-2-arachidonyl-3-phosphorylcholine affects the localization of AKT1 protein | affects localization | 15472119 |
| C468114 | 1-palmitoyl-2-arachidonyl-3-phosphorylcholine | 1-palmitoyl-2-arachidonyl-3-phosphorylcholine results in increased activity of AKT1 protein | increases activity | 15472119 |
| C417207 | 2,2',4,6,6'-pentachlorobiphenyl | SRC protein promotes the reaction [2,2',4,6,6'-pentachlorobiphenyl results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 16611624 |
| C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of AKT1 mRNA | affects expression | 21346803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Histamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11959800 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 14640974 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 19631197 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | butin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19631197 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15800129 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16272825 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19906781 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxyestradiol-17 beta results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15050414 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19059400 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Clioquinol co-treated with Copper] results in increased phosphorylation of AKT1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16648635 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Copper results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Copper Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DEFA1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19814765 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DEFA2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19814765 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16343977 16472761 16619521 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15631803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [GW0742 results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19906781 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16682453 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17550345 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[KGF protein results in increased phosphorylation of AKT1 protein] which results in increased expression of ESR1 protein] | decreases reaction|increases expression|increases phosphorylation | 19661335 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Paclitaxel results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16211241 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15919668 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phosphates results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16763222 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PTK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16168102 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15339911 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Zinc results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Zinc Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of AKT1 protein | decreases activity | 15213310 12556562 14762343 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15897870 17823925 14757120 16472761 16059913 17259349 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased activity of AKT1 protein | increases activity | 18431742 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of AKT1 protein | increases expression | 19457607 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [Sirolimus co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 18622747 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15845746 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL4 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16179367 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15178407 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17464197 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phospholipids results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15956784 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16288212 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of AKT1 protein | decreases expression | 15695173 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16256798 16179367 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [Butyrates co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 16256798 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16303940 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18388193 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17962351 11306697 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Iron results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17346750 15879002 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triiodothyronine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18096819 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 16018989 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in decreased expression of AKT1 mRNA | decreases expression | 12208782 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in decreased expression of AKT1 protein | decreases expression | 12208782 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 12208782 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 12734338 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | CNR2 protein affects the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338 |
| C548780 | 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide | 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 20861237 |
| C091768 | 3'-methoxy-4'-nitroflavone | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 12668121 |
| C025946 | 3-methyladenine | 3-methyladenine results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16882451 |
| C038864 | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | AKT1 protein results in decreased susceptibility to 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | decreases response to substance | 16417524 |
| C520164 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19906781 |
| C520164 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19906781 |
| C520164 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid | GSK0660 inhibits the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19906781 |
| C520164 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid | PPARD protein promotes the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 19906781 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [betulinic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16077934 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Paclitaxel results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16211241 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15525798 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15849355 |
| C014036 | 4-hydroxyestradiol-17 beta | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxyestradiol-17 beta results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15050414 |
| C014036 | 4-hydroxyestradiol-17 beta | 4-hydroxyestradiol-17 beta results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15050414 |
| C014036 | 4-hydroxyestradiol-17 beta | wortmannin inhibits the reaction [4-hydroxyestradiol-17 beta results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15050414 |
| C016601 | 4-hydroxytamoxifen | 4-hydroxytamoxifen results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19549922 |
| C016601 | 4-hydroxytamoxifen | AKT1 protein results in decreased susceptibility to 4-hydroxytamoxifen | decreases response to substance | 18351453 |
| C106250 | 6,7-dimethoxy-3-phenylquinoxaline | 6,7-dimethoxy-3-phenylquinoxaline results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16236484 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of AKT1 mRNA | affects expression | 17562736 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of AKT1 mRNA | affects expression | 16701773 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of AKT1 mRNA] | decreases reaction|increases expression | 16137721 |
| D000171 | Acrolein | Acrolein results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17196791 |
| D000171 | Acrolein | Acrolein results in increased expression of and results in increased phosphorylation of AKT1 protein | increases expression|increases phosphorylation | 19596284 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Fluorouracil results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18794807 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [P2RY1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16236484 |
| C412373 | AG 1879 | AG 1879 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16236484 |
| C501521 | Akt-I-1,2 compound | Akt-I-1,2 compound inhibits the reaction [Flurbiprofen results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16949054 |
| C103303 | alitretinoin | alitretinoin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16340750 |
| C103303 | alitretinoin | [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 16611854 |
| C103303 | alitretinoin | alitretinoin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16288212 |
| C103303 | alitretinoin | alitretinoin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16288212 |
| C103303 | alitretinoin | alitretinoin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 18063688 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Phosphatidic Acids results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16354768 |
| D000584 | Amiloride | Amiloride results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 16059913 15607733 |
| D000584 | Amiloride | Okadaic Acid inhibits the reaction [Amiloride results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16059913 |
| D000643 | Ammonium Chloride | Ammonium Chloride results in decreased expression of AKT1 protein | decreases expression | 16483693 |
| D000643 | Ammonium Chloride | Ammonium Chloride results in decreased expression of AKT1 protein modified form | decreases expression | 16483693 |
| D000643 | Ammonium Chloride | Ammonium Chloride results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16678351 |
| D000661 | Amphetamine | AKT1 protein affects the susceptibility to Amphetamine | affects response to substance | 14745448 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Indomethacin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one results in decreased expression of AKT1 protein | decreases expression | 16046226 |
| D047310 | Apigenin | Apigenin results in decreased expression of AKT1 protein | decreases expression | 15947208 |
| C098980 | aplidine | AKT1 protein affects the reaction [aplidine results in increased activity of MAPK8 protein] | affects reaction|increases activity | 18089842 |
| C098980 | aplidine | aplidine results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 18089842 |
| D001104 | Arbutin | Arbutin results in decreased expression of AKT1 mRNA | decreases expression | 17103032 |
| C006632 | arsenic trioxide | AKT1 protein results in decreased susceptibility to arsenic trioxide | decreases response to substance | 18048359 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of AKT1 protein | affects cotreatment|decreases expression | 17077332 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of AKT1 mRNA | decreases expression | 20458559 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased activity of AKT1 protein | increases activity | 19457607 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16882451 |
| C006632 | arsenic trioxide | [bortezomib results in decreased activity of CBL protein] promotes the reaction [arsenic trioxide results in increased activity of AKT1 protein] | decreases activity|increases activity|increases reaction | 19457607 |
| C006632 | arsenic trioxide | arsenic trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] | affects binding|decreases reaction | 15916724 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of and results in increased phosphorylation of AKT1 protein | increases expression|increases phosphorylation | 15916724 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15688020 |
| C015001 | arsenite | arsenite results in decreased expression of AKT1 mRNA | decreases expression | 18585952 |
| C015001 | arsenite | arsenite results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 14971644 |
| C015001 | arsenite | XPA protein affects the reaction [arsenite results in decreased expression of AKT1 mRNA] | affects reaction|decreases expression | 18585952 |
| C015001 | arsenite | arsenite results in increased expression of AKT1 mRNA | increases expression | 18191166 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15897870 |
| D001280 | Atrazine | Atrazine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 18461179 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of AKT1 mRNA | decreases expression | 20106945 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19181443 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased activity of and results in increased phosphorylation of AKT1 protein | increases activity|increases phosphorylation | 19801633 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | wortmannin inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased activity of and results in increased phosphorylation of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 19801633 |
| D002867 | Chromones | [Chromones analog binds to cuprous chloride] which binds to AKT1 protein | affects binding | 16789737 |
| D002867 | Chromones | [Chromones analog binds to cuprous chloride] which results in decreased activity of AKT1 protein | affects binding|decreases activity | 16789737 |
| C002070 | betulinic acid | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [betulinic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16077934 |
| C002070 | betulinic acid | betulinic acid results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16077934 |
| C053541 | bicalutamide | bicalutamide inhibits the reaction [Metribolone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17325745 |
| C034786 | bis(4-hydroxycinnamoyl)methane | AKT1 protein affects the reaction [bis(4-hydroxycinnamoyl)methane results in increased expression of HMOX1 mRNA] | affects reaction|increases expression | 17535857 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17535857 |
| C531975 | bisacurone | bisacurone inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 18602074 |
| C511635 | bis(allixinato)oxovanadium(IV) | bis(allixinato)oxovanadium(IV) results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 17805585 |
| C511635 | bis(allixinato)oxovanadium(IV) | [bis(allixinato)oxovanadium(IV) results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in increased phosphorylation of FOXO1 protein | increases activity|increases phosphorylation | 17805585 |
| C088060 | bisindolylmaleimide | bisindolylmaleimide inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [P2RY1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16236484 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 16236484 |
| C467001 | bisindolylmaleimide IX | bisindolylmaleimide IX inhibits the reaction [P2RY1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16236484 |
| C467001 | bisindolylmaleimide IX | bisindolylmaleimide IX results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 16236484 |
| C006780 | bisphenol A | bisphenol A results in increased phosphorylation of AKT1 protein | increases phosphorylation | 20096755 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of AKT1 mRNA | decreases expression | 17553608 |
| C462945 | BMS 649 | [BMS 961 co-treated with BMS 649] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 16288212 |
| C462945 | BMS 649 | [BMS 961 co-treated with BMS 649] results in increased phosphorylation of AKT1 protein | affects cotreatment|increases phosphorylation | 16288212 |
| C514178 | BMS 961 | [BMS 961 co-treated with BMS 649] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 16288212 |
| C514178 | BMS 961 | [BMS 961 co-treated with BMS 649] results in increased phosphorylation of AKT1 protein | affects cotreatment|increases phosphorylation | 16288212 |
| C400082 | bortezomib | [bortezomib results in decreased activity of CBL protein] promotes the reaction [arsenic trioxide results in increased activity of AKT1 protein] | decreases activity|increases activity|increases reaction | 19457607 |
| C400082 | bortezomib | [geldanamycin co-treated with bortezomib] results in decreased expression of AKT1 protein | affects cotreatment|decreases expression | 15781649 |
| C471992 | bosutinib | bosutinib results in decreased expression of AKT1 protein | decreases expression | 17129604 |
| C471992 | bosutinib | bosutinib results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17129604 |
| D020126 | Brefeldin A | Brefeldin A inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15525798 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [P2RY1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16236484 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15919668 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Phospholipids results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15956784 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15525798 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15705590 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14769825 |
| C051437 | butin | butin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19631197 |
| C051437 | butin | butin inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19631197 |
| C051437 | butin | butin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19631197 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17604070 |
| D002087 | Butyrates | AKT1 protein modified form results in decreased activity of [D 21266 co-treated with Butyrates] | affects cotreatment|decreases activity | 15781658 |
| D002087 | Butyrates | [D 21266 co-treated with Butyrates] results in decreased activity of AKT1 protein | affects cotreatment|decreases activity | 15781658 |
| D002087 | Butyrates | [Butyrates co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 16256798 |
| D002087 | Butyrates | Butyrates results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15978324 |
| D002104 | Cadmium | Cadmium results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17125913 |
| D002104 | Cadmium | fulvestrant inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17125913 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17125913 |
| D019256 | Cadmium Chloride | fulvestrant inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17125913 |
| D002110 | Caffeine | Caffeine results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15126379 |
| C472707 | caffeoylquinic acid | caffeoylquinic acid analog results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19647727 |
| D000001 | Calcimycin | Calcimycin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 10679475 |
| D000001 | Calcimycin | Cyclosporine inhibits the reaction [Calcimycin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 10679475 |
| D002118 | Calcium | Calcium results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15800129 |
| D002118 | Calcium | AKT1 protein affects the abundance of Calcium | affects abundance | 16094411 |
| D002118 | Calcium | AKT1 protein affects the susceptibility to Calcium | affects response to substance | 16094411 |
| D002118 | Calcium | Calcium affects the reaction [P2RY1 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 16236484 |
| D002118 | Calcium | Calcium affects the expression of AKT1 mRNA | affects expression | 15913539 |
| C059041 | calyculin A | calyculin A inhibits the reaction [Curcumin results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 18790744 |
| D002211 | Capsaicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Capsaicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19059400 |
| D002211 | Capsaicin | Capsaicin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19059400 |
| D002211 | Capsaicin | capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19059400 |
| D002211 | Capsaicin | Capsaicin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17084039 |
| C071423 | capsazepine | capsazepine inhibits the reaction [Capsaicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19059400 |
| D002248 | Carbon Monoxide | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 18037988 |
| D002248 | Carbon Monoxide | Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 17179207 |
| D002248 | Carbon Monoxide | Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 17179207 |
| D002248 | Carbon Monoxide | CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17179207 |
| D002251 | Carbon Tetrachloride | AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Cyclic GMP] | decreases abundance|decreases reaction | 12891555 |
| D002251 | Carbon Tetrachloride | AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Nitric Oxide] | decreases abundance|decreases reaction | 18245901 |
| D002251 | Carbon Tetrachloride | AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased phosphorylation of NOS3 protein] | decreases phosphorylation|decreases reaction | 12891555 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 12891555 12388182 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 18245901 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased phosphorylation of AKT1 protein | increases phosphorylation | 18317400 |
| D002251 | Carbon Tetrachloride | Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 12388182 |
| D002251 | Carbon Tetrachloride | wortmannin inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18317400 |
| D002251 | Carbon Tetrachloride | wortmannin inhibits the reaction [Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in decreased phosphorylation of AKT1 protein]] | decreases phosphorylation|decreases reaction | 12388182 |
| D002392 | Catechin | Catechin analog results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16413414 |
| C105934 | celecoxib | celecoxib results in decreased expression of AKT1 protein | decreases expression | 14654083 |
| C105934 | celecoxib | celecoxib results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17270149 |
| C105934 | celecoxib | celecoxib affects the phosphorylation of AKT1 protein | affects phosphorylation | 15570007 |
| C105934 | celecoxib | celecoxib results in decreased expression of AKT1 protein | decreases expression | 15570007 |
| C105934 | celecoxib | [celecoxib co-treated with sulindac sulfone] results in decreased expression of AKT1 protein | affects cotreatment|decreases expression | 17908994 |
| C105934 | celecoxib | [celecoxib co-treated with sulindac sulfone] results in decreased expression of AKT1 protein modified form | affects cotreatment|decreases expression | 17908994 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] results in increased expression of AKT1 mRNA | affects cotreatment|increases expression | 18636392 |
| D002784 | Cholesterol | Cholesterol results in increased expression of and results in increased phosphorylation of AKT1 protein | increases expression|increases phosphorylation | 19672739 |
| C043561 | chrysin | BCL2 protein inhibits the reaction [chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16215670 |
| C043561 | chrysin | chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 16215670 |
| C045645 | cilostazol | cilostazol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15978173 |
| D002976 | Clenbuterol | Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16339297 |
| D007464 | Clioquinol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Clioquinol co-treated with Copper] results in increased phosphorylation of AKT1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16648635 |
| D007464 | Clioquinol | [Clioquinol co-treated with Copper] results in increased phosphorylation of AKT1 protein | affects cotreatment|increases phosphorylation | 16648635 |
| D003024 | Clozapine | Clozapine results in increased expression of AKT1 mRNA | increases expression | 19440698 |
| D003024 | Clozapine | Clozapine results in increased expression of AKT1 protein | increases expression | 19440698 |
| D003024 | Clozapine | Clozapine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19440698 |
| D003024 | Clozapine | Clozapine results in decreased expression of AKT1 mRNA | decreases expression | 15860345 |
| C018021 | cobaltous chloride | AKT1 protein affects the reaction [cobaltous chloride results in increased secretion of IL8 protein] | affects reaction|increases secretion | 17082639 |
| D003300 | Copper | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Clioquinol co-treated with Copper] results in increased phosphorylation of AKT1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 16648635 |
| D003300 | Copper | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Copper results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| D003300 | Copper | [Clioquinol co-treated with Copper] results in increased phosphorylation of AKT1 protein | affects cotreatment|increases phosphorylation | 16648635 |
| D003300 | Copper | Copper results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16973122 |
| D003300 | Copper | wortmannin inhibits the reaction [Copper results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| D019327 | Copper Sulfate | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Copper Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16973122 |
| D019327 | Copper Sulfate | wortmannin inhibits the reaction [Copper Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C477330 | CP-654577 | CP-654577 results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 12907618 |
| C494620 | CPS 11 | CPS 11 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15858615 |
| C494620 | CPS 11 | CPS 11 results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15858615 |
| C494622 | CPS 49 | CPS 49 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15858615 |
| C494622 | CPS 49 | CPS 49 results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15858615 |
| C028419 | cuprous chloride | [Chromones analog binds to cuprous chloride] which binds to AKT1 protein | affects binding | 16789737 |
| C028419 | cuprous chloride | [Chromones analog binds to cuprous chloride] which results in decreased activity of AKT1 protein | affects binding|decreases activity | 16789737 |
| D003474 | Curcumin | calyculin A inhibits the reaction [Curcumin results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 18790744 |
| D003474 | Curcumin | Curcumin inhibits the reaction [CXCL12 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18660423 |
| D003474 | Curcumin | Curcumin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18214481 |
| D003474 | Curcumin | Curcumin inhibits the reaction [IL1B protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17291458 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16219905 17640567 |
| D003474 | Curcumin | Curcumin promotes the reaction [Folfox protocol results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | decreases activity|decreases expression|decreases phosphorylation|increases reaction | 17918158 |
| D003474 | Curcumin | Curcumin results in decreased activity of AKT1 protein | decreases activity | 16023083 |
| D003474 | Curcumin | Curcumin results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases expression|decreases phosphorylation | 17918158 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 18790744 17332930 17596214 17289836 19372569 |
| D003474 | Curcumin | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]] | decreases reaction|increases activity|increases phosphorylation | 17640567 |
| D003474 | Curcumin | AKT1 protein affects the reaction [Curcumin results in increased expression of HMOX1 mRNA] | affects reaction|increases expression | 17535857 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 18006147 |
| D003474 | Curcumin | Curcumin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17535857 |
| D003474 | Curcumin | AKT1 protein affects the reaction [Curcumin results in increased expression of AKR1B1 mRNA] | affects reaction|increases expression | 17640564 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 17372590 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of AKT1 mRNA | decreases expression | 20106945 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [Calcimycin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 10679475 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [Phenylephrine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 10679475 |
| D003545 | Cysteine | Cysteine inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15158331 |
| C105905 | D 21266 | AKT1 protein modified form results in decreased activity of [D 21266 co-treated with Butyrates] | affects cotreatment|decreases activity | 15781658 |
| C105905 | D 21266 | AKT1 protein modified form results in decreased activity of [D 21266 co-treated with trichostatin A] | affects cotreatment|decreases activity | 15781658 |
| C105905 | D 21266 | AKT1 protein modified form results in decreased activity of [D 21266 co-treated with vorinostat] | affects cotreatment|decreases activity | 15781658 |
| C105905 | D 21266 | [D 21266 co-treated with Butyrates] results in decreased activity of AKT1 protein | affects cotreatment|decreases activity | 15781658 |
| C105905 | D 21266 | [D 21266 co-treated with trichostatin A] results in decreased activity of AKT1 protein | affects cotreatment|decreases activity | 15781658 |
| C105905 | D 21266 | [D 21266 co-treated with vorinostat] results in decreased activity of AKT1 protein | affects cotreatment|decreases activity | 15781658 |
| D003609 | Dactinomycin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 14640974 |
| D003609 | Dactinomycin | Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 14640974 |
| D003609 | Dactinomycin | PLD1 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974 |
| D003609 | Dactinomycin | PLD2 protein promotes the reaction [Dactinomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | increases activity|increases phosphorylation|increases reaction | 14640974 |
| D016047 | Zalcitabine | Zalcitabine affects the phosphorylation of AKT1 protein | affects phosphorylation | 19781600 |
| C014347 | decitabine | decitabine results in decreased activity of AKT1 protein | decreases activity | 18636160 |
| C014347 | decitabine | decitabine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 21170675 |
| C044919 | deferiprone | deferiprone inhibits the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C044919 | deferiprone | deferiprone inhibits the reaction [Iron results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D003676 | Deferoxamine | Deferoxamine inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18032466 |
| C107676 | deguelin | deguelin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17015749 |
| C107676 | deguelin | deguelin metabolite results in decreased expression of AKT1 protein | decreases expression | 19139008 |
| C107676 | deguelin | deguelin results in decreased expression of AKT1 protein | decreases expression | 19336726 19139008 |
| C107676 | deguelin | deguelin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 19336726 18593368 |
| C107676 | deguelin | deguelin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16288123 |
| D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16373398 |
| D003687 | Dehydroepiandrosterone | wortmannin inhibits the reaction [Dehydroepiandrosterone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16373398 |
| C050229 | demethoxycurcumin | AKT1 protein affects the reaction [demethoxycurcumin results in increased expression of HMOX1 mRNA] | affects reaction|increases expression | 17535857 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17535857 |
| C007262 | deoxynivalenol | AKT1 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA] | affects reaction|increases expression | 16424113 |
| C007262 | deoxynivalenol | AKT1 protein affects the reaction [deoxynivalenol results in increased phosphorylation of CREB1 protein] | affects reaction|increases phosphorylation | 16424113 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16424113 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15976193 |
| C007262 | deoxynivalenol | Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16424113 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased expression of AKT1 protein | decreases expression | 16099139 |
| C061481 | dibenzoylmethane | [dibenzoylmethane co-treated with sulforafan] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 17942926 |
| C061481 | dibenzoylmethane | dibenzoylmethane results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17942926 |
| D002945 | Cisplatin | Cisplatin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15981204 |
| D004052 | Diethylnitrosamine | CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 20583210 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 20583210 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of AKT1 | increases expression | 17055752 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15171707 |
| C007409 | dihydrolipoamide | dihydrolipoamide inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15613977 |
| D002117 | Calcitriol | Calcitriol inhibits the reaction [IL2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15879110 |
| D017878 | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | AKT1 protein affects the reaction [4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]] | affects reaction|decreases reaction|increases activity | 18164246 |
| D011397 | Promegestone | fulvestrant inhibits the reaction [Promegestone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16020483 |
| D011397 | Promegestone | Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16020483 |
| D011397 | Promegestone | Promegestone results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16020483 |
| D004144 | Diosgenin | Diosgenin inhibits the reaction [TNF protein results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16331273 |
| D004178 | Diquat | Diquat results in increased phosphorylation of AKT1 protein | increases phosphorylation | 20826540 |
| D004178 | Diquat | PROP1 protein affects the reaction [Diquat results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 20826540 |
| D004280 | Dobutamine | AKT1 protein affects the susceptibility to Dobutamine | affects response to substance | 16094411 |
| D004280 | Dobutamine | Dobutamine inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16339297 |
| D004281 | Docosahexaenoic Acids | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of AKT1 protein | affects cotreatment|decreases expression | 17077332 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16424113 |
| D017292 | Doxazosin | Doxazosin affects the phosphorylation of AKT1 protein | affects phosphorylation | 18084315 |
| D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PTK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16168102 |
| D004317 | Doxorubicin | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| D004317 | Doxorubicin | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| D004317 | Doxorubicin | AKT1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 16782806 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16740780 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of AKT1 protein modified form | decreases expression | 16438844 |
| D004317 | Doxorubicin | Doxorubicin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15494689 16168102 17359293 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17339365 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16168102 17935137 |
| D004317 | Doxorubicin | ERBB2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 16168102 |
| D004317 | Doxorubicin | ERBB3 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16168102 |
| D004317 | Doxorubicin | methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17339365 |
| D004317 | Doxorubicin | [methylselenic acid results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin | decreases phosphorylation|increases response to substance | 17339365 |
| D004317 | Doxorubicin | PTEN protein inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17935137 |
| D004317 | Doxorubicin | PTEN protein promotes the reaction [Doxorubicin results in decreased expression of AKT1 protein modified form] | decreases expression|increases reaction | 16438844 |
| D004317 | Doxorubicin | PTEN protein promotes the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|increases reaction | 17359293 |
| D004317 | Doxorubicin | PTK2B protein inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16168102 |
| D004317 | Doxorubicin | PTK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 16168102 |
| D004317 | Doxorubicin | Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17339365 |
| D004317 | Doxorubicin | [Selenium results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin | decreases phosphorylation|increases response to substance | 17339365 |
| D004317 | Doxorubicin | BDKRB1 protein affects the reaction [Doxorubicin results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | affects reaction|decreases activity|decreases phosphorylation | 18627295 |
| D004317 | Doxorubicin | Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 18037988 |
| D004317 | Doxorubicin | Doxorubicin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 18037988 |
| D004317 | Doxorubicin | Doxorubicin results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 18627295 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17531194 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of AKT1 protein] | affects phosphorylation|affects reaction | 15833803 |
| D004317 | Doxorubicin | AKT1 protein affects the reaction [4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]] | affects reaction|decreases reaction|increases activity | 18164246 |
| D004317 | Doxorubicin | AKT1 protein inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA] | decreases reaction|increases expression | 18346979 |
| D004317 | Doxorubicin | dihydrolipoamide inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15613977 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17308081 16926266 15613977 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16825486 |
| D004317 | Doxorubicin | H 2545 inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15613977 |
| D004317 | Doxorubicin | wortmannin inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16825486 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19647727 |
| D004642 | Emodin | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of AKT1 protein | affects cotreatment|decreases expression | 17077332 |
| D004642 | Emodin | Emodin results in decreased expression of AKT1 mRNA | decreases expression | 16045814 |
| D004642 | Emodin | Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15288473 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [HGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19244381 |
| C007610 | equol | equol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16840783 |
| C073539 | erucin | erucin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15896333 |
| D004958 | Estradiol | AKT1 protein affects the reaction [Estradiol results in increased expression of CCND1 protein] | affects reaction|increases expression | 20228224 |
| D004958 | Estradiol | BRCA1 protein inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 18997820 |
| D004958 | Estradiol | Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein] | affects binding|increases reaction | 19435893 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16168102 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 18997820 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of and results in increased activity of and results in increased localization of AKT1 protein | increases activity|increases localization|increases phosphorylation | 20228224 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16168102 |
| D004958 | Estradiol | NVP-AEW541 inhibits the reaction [Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein]] | affects binding|decreases reaction|increases reaction | 19435893 |
| D004958 | Estradiol | PTEN protein affects the reaction [Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein]] | affects binding|affects reaction|increases reaction | 19435893 |
| D004958 | Estradiol | TCL1B protein promotes the reaction [Estradiol results in increased phosphorylation of and results in increased activity of and results in increased localization of AKT1 protein] | increases activity|increases localization|increases phosphorylation|increases reaction | 20228224 |
| D004958 | Estradiol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15845746 |
| D004958 | Estradiol | Estradiol affects the expression of AKT1 mRNA | affects expression | 15598610 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15845746 |
| D004958 | Estradiol | Progesterone inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15845746 |
| D004958 | Estradiol | wortmannin inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15845746 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15590986 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17348974 |
| D000431 | Ethanol | Ethanol results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 18295389 |
| D000431 | Ethanol | [Fish Oils co-treated with Ethanol] results in increased expression of AKT1 mRNA | affects cotreatment|increases expression | 17347304 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of AKT1 mRNA | increases expression | 17555576 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AKT1 mRNA | affects cotreatment|increases expression | 17942748 |
| D005047 | Etoposide | Etoposide results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 17935137 |
| D005047 | Etoposide | PTEN protein inhibits the reaction [Etoposide results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17935137 |
| C107135 | everolimus | everolimus results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16033851 |
| C049639 | evodiamine | evodiamine inhibits the reaction [TNF protein results in increased activity of AKT1 protein] | decreases reaction|increases activity | 15710601 |
| D018690 | Excitatory Amino Acid Agonists | Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 19201465 |
| D018690 | Excitatory Amino Acid Agonists | mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19201465 |
| D018690 | Excitatory Amino Acid Agonists | morin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19201465 |
| C063007 | exoenzyme C3, Clostridium botulinum | exoenzyme C3, Clostridium botulinum inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14769825 |
| C093323 | farnesylthiosalicylic acid | farnesylthiosalicylic acid results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16780807 |
| C049347 | fasudil | fasudil results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 17761835 |
| C020748 | ferrous sulfate | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | deferiprone inhibits the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | ferrous sulfate results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | MAP3K7 protein affects the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 17172471 |
| C020748 | ferrous sulfate | PIK3R1 protein affects the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 17172471 |
| D005372 | Filipin | Filipin inhibits the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D005372 | Filipin | Filipin inhibits the reaction [Iron results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D005395 | Fish Oils | [Fish Oils co-treated with Ethanol] results in increased expression of AKT1 mRNA | affects cotreatment|increases expression | 17347304 |
| C024352 | fludarabine | fludarabine results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 15213310 |
| C024352 | fludarabine | fludarabine results in increased activity of AKT1 protein | increases activity | 15059916 |
| D015073 | 2-Acetylaminofluorene | [2-Acetylaminofluorene results in increased activity of AKT1 protein] which results in increased expression of ABCB1 mRNA | increases activity|increases expression | 11960367 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 11960367 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 17303067 |
| D015073 | 2-Acetylaminofluorene | Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17303067 |
| D005472 | Fluorouracil | AG 1879 inhibits the reaction [Fluorouracil results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18794807 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases expression|decreases phosphorylation | 17918158 |
| D005472 | Fluorouracil | Fluorouracil results in increased phosphorylation of AKT1 protein | increases phosphorylation | 18794807 |
| D005472 | Fluorouracil | Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16724238 |
| D005480 | Flurbiprofen | AKT1 protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] | affects reaction|increases expression | 16949054 |
| D005480 | Flurbiprofen | Akt-I-1,2 compound inhibits the reaction [Flurbiprofen results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16949054 |
| D005480 | Flurbiprofen | Flurbiprofen results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16949054 |
| D005480 | Flurbiprofen | [Flurbiprofen results in increased phosphorylation of and results in increased activity of PSCA protein] which results in increased expression of AKT1 protein | increases activity|increases expression|increases phosphorylation | 16949054 |
| C410216 | Folfox protocol | Curcumin promotes the reaction [Folfox protocol results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | decreases activity|decreases expression|decreases phosphorylation|increases reaction | 17918158 |
| C410216 | Folfox protocol | Folfox protocol results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases expression|decreases phosphorylation | 17918158 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15925284 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15925284 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16621998 |
| D005576 | Forskolin | Forskolin inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16339297 |
| D005632 | Fructose | Fructose results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 18497449 19008412 |
| D005632 | Fructose | NOS3 protein inhibits the reaction [Fructose results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19008412 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17125913 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Cadmium results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17125913 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16168102 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Promegestone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16020483 |
| D005665 | Furosemide | Furosemide affects the phosphorylation of AKT1 protein | affects phosphorylation | 17497460 |
| C054597 | garcinol | garcinol results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 16052481 |
| C419708 | gefitinib | gefitinib inhibits the reaction [Dinoprostone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17805209 |
| C419708 | gefitinib | gefitinib inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19233551 |
| C001277 | geldanamycin | [geldanamycin co-treated with bortezomib] results in decreased expression of AKT1 protein | affects cotreatment|decreases expression | 15781649 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Tretinoin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17293044 |
| C001277 | geldanamycin | geldanamycin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17293044 |
| D019833 | Genistein | Genistein binds to AKT1 protein | affects binding | 16789737 |
| D019833 | Genistein | Genistein inhibits the reaction [EGF protein results in increased activity of AKT1 protein] | decreases reaction|increases activity | 18431742 |
| D019833 | Genistein | Genistein results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 18431742 15829497 |
| D019833 | Genistein | [[Genistein results in increased expression of PTEN protein] which results in decreased activity of AKT1 protein] which results in increased activity of FOXO3 protein | decreases activity|increases activity|increases expression | 18431742 |
| D019833 | Genistein | [[Genistein results in increased expression of PTEN protein] which results in decreased activity of AKT1 protein] which results in increased expression of TP53 protein | decreases activity|increases expression | 18431742 |
| D019833 | Genistein | Genistein results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17141266 |
| D005839 | Gentamicins | Gentamicins results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15800129 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 affects the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 19414004 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [APP protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 19464278 |
| C045856 | ginkgolide B | ginkgolide B inhibits the reaction [APP protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 19464278 |
| D005947 | Glucose | Metformin inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16385087 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]] | decreases reaction|increases activity|increases phosphorylation | 17640567 |
| C081021 | Go 6976 | Go 6976 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 19393235 |
| C529769 | GSK0660 | GSK0660 inhibits the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19906781 |
| C529769 | GSK0660 | GSK0660 inhibits the reaction [GW0742 results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19906781 |
| D006152 | Cyclic GMP | AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Cyclic GMP] | decreases abundance|decreases reaction | 12891555 |
| C479979 | GW0742 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [GW0742 results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19906781 |
| C479979 | GW0742 | GSK0660 inhibits the reaction [GW0742 results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19906781 |
| C479979 | GW0742 | GW0742 results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19906781 |
| C479979 | GW0742 | PPARD protein promotes the reaction [GW0742 results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 19906781 |
| C441088 | H 2545 | H 2545 inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15613977 |
| D006220 | Haloperidol | Haloperidol results in decreased expression of AKT1 mRNA | decreases expression | 15860345 |
| D006493 | Heparin | Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14966081 |
| D006493 | Heparin | Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14966081 |
| D006581 | Hexachlorobenzene | AKT1 protein promotes the reaction [Hexachlorobenzene results in decreased expression of GJB1 mRNA] | decreases expression|increases reaction | 17150971 |
| D006581 | Hexachlorobenzene | AKT1 protein promotes the reaction [Hexachlorobenzene results in decreased expression of GJB1 protein] | decreases expression|increases reaction | 17150971 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased activity of and results in increased localization of AKT1 protein | increases activity|increases localization | 16679308 |
| D006588 | Hexanones | Hexanones results in increased phosphorylation of AKT1 protein | increases phosphorylation | 14757120 |
| D006588 | Hexanones | wortmannin inhibits the reaction [Hexanones results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14757120 |
| D006632 | Histamine | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Histamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11959800 |
| D006632 | Histamine | Histamine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 11959800 |
| D006632 | Histamine | Pertussis Toxin inhibits the reaction [Histamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11959800 |
| D006632 | Histamine | Pyrilamine inhibits the reaction [Histamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11959800 |
| D006632 | Histamine | wortmannin inhibits the reaction [Histamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11959800 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16230421 |
| D006812 | Humic Substances | Humic Substances results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19686714 |
| D006812 | Humic Substances | wortmannin inhibits the reaction [Humic Substances results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19686714 |
| D006843 | Hydrocarbons, Chlorinated | Hydrocarbons, Chlorinated results in increased phosphorylation of AKT1 protein | increases phosphorylation | 14757120 |
| D006843 | Hydrocarbons, Chlorinated | wortmannin inhibits the reaction [Hydrocarbons, Chlorinated results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14757120 |
| D006861 | Hydrogen Peroxide | butin inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19631197 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 19631197 |
| D006861 | Hydrogen Peroxide | Ginkgo biloba extract 761 affects the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 19414004 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [Metribolone results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 17325745 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 19451193 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 19414004 |
| D006861 | Hydrogen Peroxide | AXL protein promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 15123721 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 17997286 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15123721 |
| D006861 | Hydrogen Peroxide | Selenium inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 17997286 |
| D006861 | Hydrogen Peroxide | 1-Butanol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15705590 |
| D006861 | Hydrogen Peroxide | [Hydrogen Peroxide co-treated with RLN2 protein] results in increased phosphorylation of AKT1 protein | affects cotreatment|increases phosphorylation | 17204550 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15705590 |
| D006861 | Hydrogen Peroxide | Pertussis Toxin inhibits the reaction [[Hydrogen Peroxide co-treated with RLN2 protein] results in increased phosphorylation of AKT1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 17204550 |
| D006861 | Hydrogen Peroxide | PLD2 protein affects the reaction [Hydrogen Peroxide results in increased activity of and results in increased phosphorylation of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 15705590 |
| D006861 | Hydrogen Peroxide | PTK2B protein affects the reaction [Hydrogen Peroxide results in increased activity of and results in increased phosphorylation of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 15705590 |
| C031927 | hydroquinone | hydroquinone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17464197 |
| D016627 | Oxidopamine | Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16339297 |
| D016627 | Oxidopamine | Dobutamine inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16339297 |
| D016627 | Oxidopamine | Forskolin inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16339297 |
| D016627 | Oxidopamine | Oxidopamine results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16339297 |
| D004441 | Ecdysterone | Ecdysterone results in decreased expression of AKT1 mRNA | decreases expression | 15776001 |
| C477872 | IC 87114 | IC 87114 inhibits the reaction [IL4 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16179367 |
| C477872 | IC 87114 | IC 87114 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16179367 |
| C097613 | imatinib | imatinib results in increased phosphorylation of AKT1 protein | increases phosphorylation | 12032135 |
| C097613 | imatinib | imatinib promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16740780 |
| C097613 | imatinib | imatinib results in decreased expression of AKT1 mRNA | decreases expression | 19208803 |
| C097613 | imatinib | imatinib results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15786421 |
| C097613 | imatinib | imatinib results in decreased expression of AKT1 protein | decreases expression | 17129604 |
| C097613 | imatinib | imatinib results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17129604 |
| C097613 | imatinib | imatinib results in increased phosphorylation of AKT1 protein | increases phosphorylation | 12032135 |
| C078038 | inchinko-to | inchinko-to inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15288473 |
| D007213 | Indomethacin | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Indomethacin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of AKT1 protein modified form | decreases expression | 17654042 |
| D007213 | Indomethacin | Indomethacin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17341418 |
| D007213 | Indomethacin | SB 203580 inhibits the reaction [Indomethacin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| D007213 | Indomethacin | TXN protein inhibits the reaction [Indomethacin results in decreased expression of AKT1 protein modified form] | decreases expression|decreases reaction | 17654042 |
| D007213 | Indomethacin | U 0126 inhibits the reaction [Indomethacin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| D007501 | Iron | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Iron results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | deferiprone inhibits the reaction [Iron results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | Filipin inhibits the reaction [Iron results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | HRAS protein affects the reaction [Iron results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | Iron results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17172471 |
| D007501 | Iron | MAP3K7 protein affects the reaction [Iron results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 17172471 |
| D007501 | Iron | PIK3R1 protein affects the reaction [Iron results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 17172471 |
| D007545 | Isoproterenol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15178407 |
| D007545 | Isoproterenol | Isoproterenol results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15178407 |
| D007545 | Isoproterenol | wortmannin inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15178407 |
| D007545 | Isoproterenol | [PDE3B protein co-treated with AKT1 protein] inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19167487 |
| C088327 | JM 3100 | JM 3100 inhibits the reaction [CXCL12 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18660423 |
| C006552 | kaempferol | kaempferol inhibits the reaction [HGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19244381 |
| C510621 | KCC 009 | KCC 009 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16170020 |
| C456099 | KF58333 | KF58333 results in decreased expression of AKT1 protein | decreases expression | 11800023 |
| C011890 | kojic acid | kojic acid results in decreased expression of AKT1 mRNA | decreases expression | 16595896 |
| C490728 | lapatinib | lapatinib results in decreased activity of AKT1 protein | decreases activity | 15665275 |
| C490728 | lapatinib | lapatinib results in decreased expression of AKT1 protein | decreases expression | 16091755 |
| C490728 | lapatinib | lapatinib results in decreased expression of AKT1 protein modified form | decreases expression | 19435893 |
| D016729 | Leuprolide | Leuprolide inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17143537 |
| D008043 | Linseed Oil | Linseed Oil results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 21138602 |
| D008070 | Lipopolysaccharides | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17464197 |
| D008070 | Lipopolysaccharides | Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16724238 |
| D008070 | Lipopolysaccharides | hydroquinone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17464197 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 17131360 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of AKT1 protein | increases phosphorylation | 18683823 16724238 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 17464197 |
| D008070 | Lipopolysaccharides | shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18683823 |
| D008070 | Lipopolysaccharides | wortmannin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17464197 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17172471 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 18538761 |
| D008070 | Lipopolysaccharides | Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 18538761 |
| D008094 | Lithium | Lithium results in increased expression of AKT1 mRNA | increases expression | 19440698 |
| D008094 | Lithium | Lithium results in increased expression of AKT1 protein | increases expression | 19440698 |
| D008094 | Lithium | Lithium results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19440698 |
| C025430 | LY 117018 | LY 117018 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15876410 |
| C015329 | lycopene | lycopene results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17337101 |
| C032881 | lysophosphatidic acid | lysophosphatidic acid results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17550345 |
| C032881 | lysophosphatidic acid | resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17550345 |
| C032881 | lysophosphatidic acid | 1-Butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14769825 |
| C032881 | lysophosphatidic acid | exoenzyme C3, Clostridium botulinum inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14769825 |
| C032881 | lysophosphatidic acid | lysophosphatidic acid results in increased phosphorylation of AKT1 protein | increases phosphorylation | 14769825 |
| D008345 | Manganese | Manganese results in decreased expression of AKT1 protein | decreases expression | 17043766 |
| C013592 | mangiferin | mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19201465 |
| D008687 | Metformin | Metformin inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16385087 |
| D008687 | Metformin | Metformin inhibits the reaction [IL1B protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16385087 |
| D008715 | Methionine | Methionine inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15158331 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 17298174 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15581186 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15247282 |
| C008493 | methylselenic acid | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| C008493 | methylselenic acid | AKT1 protein results in decreased susceptibility to methylselenic acid | decreases response to substance | 15845651 |
| C008493 | methylselenic acid | methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17339365 |
| C008493 | methylselenic acid | methylselenic acid results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17339365 15845651 |
| C008493 | methylselenic acid | [methylselenic acid results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin | decreases phosphorylation|increases response to substance | 17339365 |
| D015741 | Metribolone | bicalutamide inhibits the reaction [Metribolone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17325745 |
| D015741 | Metribolone | Hydrogen Peroxide promotes the reaction [Metribolone results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 17325745 |
| D015741 | Metribolone | Metribolone results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17325745 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16020483 |
| C008542 | monodansylcadaverine | monodansylcadaverine results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16170020 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of AKT1 mRNA | increases expression | 20024957 |
| C008548 | morin | morin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19201465 |
| C107728 | MRS 1191 | MRS 1191 inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15879002 |
| C084956 | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | Pertussis Toxin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16116186 |
| C084956 | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | wortmannin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16116186 |
| C064769 | N-acetylsphingosine | BCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16215670 |
| C064769 | N-acetylsphingosine | N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 16215670 |
| D009355 | Neomycin | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15800129 |
| D009355 | Neomycin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15800129 |
| D009355 | Neomycin | Neomycin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15800129 |
| D009355 | Neomycin | wortmannin inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15800129 |
| D009534 | Niclosamide | Niclosamide inhibits the reaction [TNF protein results in increased activity of AKT1 protein] | decreases reaction|increases activity | 20215516 |
| D009538 | Nicotine | Nicotine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15983034 |
| C021277 | nilutamide | nilutamide results in increased expression of AKT1 protein | increases expression | 16616092 |
| D009569 | Nitric Oxide | [[rottlerin results in decreased activity of AKT1 protein] which results in decreased phosphorylation of and results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases activity|decreases chemical synthesis|decreases phosphorylation | 18192589 |
| D009569 | Nitric Oxide | AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Nitric Oxide] | decreases abundance|decreases reaction | 18245901 |
| D026422 | S-Nitrosoglutathione | AKT1 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein] | decreases reaction|increases expression | 11514583 |
| C511689 | (N)-methanocarba-2MeSADP | ADRBK1 protein inhibits the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16236484 |
| C511689 | (N)-methanocarba-2MeSADP | (N)-methanocarba-2MeSADP results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16236484 |
| C511689 | (N)-methanocarba-2MeSADP | PRKCZ protein inhibits the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16236484 |
| C511689 | (N)-methanocarba-2MeSADP | RAP1GAP protein inhibits the reaction [(N)-methanocarba-2MeSADP results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16236484 |
| C404397 | NSC 680410 | NSC 680410 results in decreased expression of AKT1 protein | decreases expression | 14647418 |
| C404397 | NSC 680410 | NSC 680410 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 14647418 |
| C502355 | NVP ADW742 | Doxorubicin promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16740780 |
| C502355 | NVP ADW742 | imatinib promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16740780 |
| C502355 | NVP ADW742 | NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16740780 |
| C502355 | NVP ADW742 | Vincristine promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16740780 |
| C501177 | NVP-AEW541 | NVP-AEW541 inhibits the reaction [Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein]] | affects binding|decreases reaction|increases reaction | 19435893 |
| C501177 | NVP-AEW541 | NVP-AEW541 results in decreased expression of AKT1 protein modified form | decreases expression | 19435893 |
| C531198 | NVP BEZ235 | NVP BEZ235 results in decreased expression of AKT1 protein modified form | decreases expression | 19435893 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of AKT1 mRNA | increases expression | 16251485 |
| D019319 | Okadaic Acid | Okadaic Acid inhibits the reaction [Amiloride results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 16059913 |
| C076029 | olanzapine | olanzapine results in increased expression of AKT1 mRNA | increases expression | 19440698 |
| C076029 | olanzapine | olanzapine results in increased expression of AKT1 protein | increases expression | 19440698 |
| C076029 | olanzapine | olanzapine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19440698 |
| C488250 | oleoylethanolamide | oleoylethanolamide affects the phosphorylation of and affects the activity of AKT1 protein | affects activity|affects phosphorylation | 19345745 |
| D053683 | Oncostatin M | Oncostatin M results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15654950 |
| D016566 | Organoselenium Compounds | Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 18538761 |
| C030110 | oxaliplatin | AKT1 protein affects the susceptibility to oxaliplatin | affects response to substance | 19147571 |
| C030110 | oxaliplatin | oxaliplatin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19147571 |
| C030110 | oxaliplatin | oxaliplatin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 18790786 |
| D010100 | Oxygen | [AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein]] which affects the susceptibility to Oxygen | affects reaction|affects response to substance|decreases expression | 18924134 |
| D010126 | Ozone | Ozone results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19536146 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] results in increased expression of AKT1 mRNA | affects cotreatment|increases expression | 18636392 |
| D017239 | Paclitaxel | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Paclitaxel results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16211241 |
| D017239 | Paclitaxel | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Paclitaxel results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16211241 |
| D017239 | Paclitaxel | AKT1 protein affects the susceptibility to Paclitaxel | affects response to substance | 18071906 |
| D017239 | Paclitaxel | AKT1 protein results in decreased susceptibility to Paclitaxel | decreases response to substance | 16782806 |
| D017239 | Paclitaxel | Paclitaxel results in increased activity of AKT1 protein | increases activity | 16211241 |
| D017239 | Paclitaxel | [pifithrin co-treated with Paclitaxel] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 18516295 |
| D017239 | Paclitaxel | U 0126 inhibits the reaction [Paclitaxel results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16211241 |
| D010269 | Paraquat | Paraquat results in decreased expression of AKT1 mRNA | decreases expression | 16797015 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15608143 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Progesterone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15358673 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [Histamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11959800 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [C5 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16116186 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16116186 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [[Hydrogen Peroxide co-treated with RLN2 protein] results in increased phosphorylation of AKT1 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 17204550 |
| D010637 | Phenolsulfonphthalein | Phenolsulfonphthalein results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 17203231 |
| D010656 | Phenylephrine | Cyclosporine inhibits the reaction [Phenylephrine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 10679475 |
| D010656 | Phenylephrine | Phenylephrine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 10679475 |
| D010656 | Phenylephrine | Phenylephrine affects the phosphorylation of AKT1 protein | affects phosphorylation | 18084315 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [[IL1B protein results in increased phosphorylation of AKT1 protein] which results in increased expression of IL1R1 mRNA] | decreases reaction|increases expression|increases phosphorylation | 18078833 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [[IL1B protein results in increased phosphorylation of AKT1 protein] which results in increased expression of IL1R1 protein] | decreases reaction|increases expression|increases phosphorylation | 18078833 |
| D010710 | Phosphates | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phosphates results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16763222 |
| D010710 | Phosphates | AKT1 protein affects the reaction [Phosphates results in increased expression of MKNK1 mRNA] | affects reaction|increases expression | 16763222 |
| D010710 | Phosphates | AKT1 protein affects the reaction [Phosphates results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 16763222 |
| D010710 | Phosphates | AKT1 protein affects the reaction [Phosphates results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 16763222 |
| D010710 | Phosphates | Phosphates results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16763222 |
| D010712 | Phosphatidic Acids | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Phosphatidic Acids results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16354768 |
| D010712 | Phosphatidic Acids | R 59949 inhibits the reaction [Phosphatidic Acids results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15525798 |
| D010743 | Phospholipids | 1-Butanol inhibits the reaction [Phospholipids results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15956784 |
| D010743 | Phospholipids | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phospholipids results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15956784 |
| D010743 | Phospholipids | Phospholipids results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15956784 |
| C008890 | phosphoramidon | phosphoramidon inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| D010798 | Phycocyanin | Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17303067 |
| D010833 | Phytic Acid | Phytic Acid results in decreased activity of AKT1 protein | decreases activity | 15868430 |
| C121565 | pifithrin | [pifithrin co-treated with Paclitaxel] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 18516295 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of and results in increased phosphorylation of AKT1 protein | increases expression|increases phosphorylation | 19151258 |
| D017035 | Pravastatin | Pravastatin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17188708 |
| D017035 | Pravastatin | [resveratrol co-treated with Pravastatin] results in increased phosphorylation of AKT1 protein | affects cotreatment|increases phosphorylation | 17188708 |
| D011374 | Progesterone | PD 98059 inhibits the reaction [Progesterone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15358673 |
| D011374 | Progesterone | Progesterone results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15358673 |
| D011374 | Progesterone | Progesterone inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15845746 |
| D015232 | Dinoprostone | Dinoprostone results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17805209 |
| D015232 | Dinoprostone | gefitinib inhibits the reaction [Dinoprostone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17805209 |
| D011738 | Pyrilamine | Pyrilamine inhibits the reaction [Histamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11959800 |
| C008704 | pyrithione | AKT1 protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein] | affects cotreatment|increases activity|increases phosphorylation|increases reaction | 17098228 |
| C008704 | pyrithione | [Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of AKT1 protein | affects cotreatment|increases activity|increases phosphorylation | 17098228 |
| D011794 | Quercetin | Quercetin inhibits the reaction [APP protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 19464278 |
| D011794 | Quercetin | Quercetin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16619521 |
| D011794 | Quercetin | Quercetin inhibits the reaction [HGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19244381 |
| D011794 | Quercetin | Quercetin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15741050 15829497 17973296 16794257 |
| D011794 | Quercetin | Quercetin results in increased expression of AKT1 mRNA | increases expression | 14715546 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17449583 |
| D011794 | Quercetin | Quercetin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11306697 17962351 |
| C058544 | R 59949 | R 59949 inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15525798 |
| C058544 | R 59949 | R 59949 inhibits the reaction [Phosphatidic Acids results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15525798 |
| D020849 | Raloxifene | Raloxifene results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15876410 |
| D020849 | Raloxifene | Raloxifene results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16798746 |
| D020849 | Raloxifene | Raloxifene results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15590986 |
| D020849 | Raloxifene | Raloxifene results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17348974 |
| C059514 | resveratrol | resveratrol inhibits the reaction [AKT1 protein results in increased phosphorylation of FOXO1 protein] | decreases reaction|increases phosphorylation | 16343977 |
| C059514 | resveratrol | resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16343977 |
| C059514 | resveratrol | resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17513867 |
| C059514 | resveratrol | resveratrol inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17550345 16626303 |
| C059514 | resveratrol | resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17550345 |
| C059514 | resveratrol | resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15925284 |
| C059514 | resveratrol | resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16343977 |
| C059514 | resveratrol | resveratrol inhibits the reaction [PIK3CA protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17550345 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16731767 17823925 16979140 15829497 17044934 17486135 17164350 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 17868649 16626303 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17499741 |
| C059514 | resveratrol | PTPN11 protein affects the reaction [resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]] | affects reaction|decreases reaction|increases activity|increases phosphorylation | 15849355 |
| C059514 | resveratrol | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15879002 17346750 |
| C059514 | resveratrol | MRS 1191 inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15879002 |
| C059514 | resveratrol | [resveratrol co-treated with Pravastatin] results in increased phosphorylation of AKT1 protein | affects cotreatment|increases phosphorylation | 17188708 |
| C059514 | resveratrol | resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15849355 |
| C059514 | resveratrol | resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16626303 15849355 |
| C059514 | resveratrol | resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16626303 |
| C059514 | resveratrol | resveratrol inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17550345 16626303 |
| C059514 | resveratrol | resveratrol results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 16626303 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17015251 16525036 17346750 17188708 15879002 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15882976 16860989 |
| C059514 | resveratrol | tin protoporphyrin IX inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17015251 |
| C059514 | resveratrol | wortmannin inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17346750 |
| D012402 | Rotenone | Rotenone affects the phosphorylation of AKT1 protein | affects phosphorylation | 19781600 |
| C085746 | rottlerin | rottlerin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C085746 | rottlerin | rottlerin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 19393235 |
| C085746 | rottlerin | [rottlerin affects the activity of AKT1 protein] which results in decreased phosphorylation of and results in decreased activity of NOS3 protein | affects activity|decreases activity|decreases phosphorylation | 18192589 |
| C085746 | rottlerin | [rottlerin results in decreased activity of AKT1 protein] which results in decreased expression of NOS3 mRNA | decreases activity|decreases expression | 18192589 |
| C085746 | rottlerin | [[rottlerin results in decreased activity of AKT1 protein] which results in decreased phosphorylation of and results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide | decreases activity|decreases chemical synthesis|decreases phosphorylation | 18192589 |
| C085746 | rottlerin | [rottlerin results in decreased activity of PRKCD protein] which results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 18192589 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Indomethacin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| D012643 | Selenium | AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] | affects cotreatment|decreases reaction|increases degradation | 17339365 |
| D012643 | Selenium | Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17339365 |
| D012643 | Selenium | Selenium results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17339365 |
| D012643 | Selenium | [Selenium results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin | decreases phosphorylation|increases response to substance | 17339365 |
| D012643 | Selenium | Selenium results in increased expression of AKT1 mRNA | increases expression | 19244175 |
| D012643 | Selenium | Selenium results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 18583539 |
| D012643 | Selenium | Selenium inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 17997286 |
| C516024 | SH-6 compound | SH-6 compound results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17289836 |
| C516024 | SH-6 compound | [SH-6 compound results in decreased phosphorylation of AKT1 protein] which results in decreased expression of and results in decreased activity of RELA protein | decreases activity|decreases expression|decreases phosphorylation | 17289836 |
| C040115 | shogaol | shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18683823 |
| C101426 | sildenafil | sildenafil results in increased phosphorylation of AKT1 protein | increases phosphorylation | 18373738 |
| D019821 | Simvastatin | Simvastatin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 17335931 |
| D020123 | Sirolimus | [Sirolimus co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 18622747 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TSC1 gene mutant form results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 18495876 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of AKT1 mRNA | decreases expression | 12760830 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of AKT1 protein | increases phosphorylation | 12482858 |
| C017947 | sodium arsenite | wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 12482858 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of AKT1 mRNA | decreases expression | 19822182 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of AKT1 protein | decreases expression | 12760830 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of AKT1 mRNA | decreases expression | 12760830 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of AKT1 protein | decreases expression | 12760830 |
| D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of AKT1 mRNA | decreases expression | 16705456 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased phosphorylation of AKT1 protein | increases phosphorylation | 12896980 15845651 |
| C060506 | sphingosine 1-phosphate | sphingosine 1-phosphate results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16365044 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| D019311 | Staurosporine | Staurosporine promotes the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] | increases phosphorylation|increases reaction | 11306697 |
| D019311 | Staurosporine | Staurosporine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 11306697 |
| D013267 | Stilbenes | Stilbenes analog results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 18449500 |
| C105686 | SU 5402 | SU 5402 inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15631803 |
| C116890 | SU 5416 | SU 5416 results in decreased activity of AKT1 protein | decreases activity | 15474452 |
| C016766 | sulforafan | sulforafan results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 15896333 |
| C016766 | sulforafan | [dibenzoylmethane co-treated with sulforafan] results in decreased phosphorylation of AKT1 protein | affects cotreatment|decreases phosphorylation | 17942926 |
| C016766 | sulforafan | sulforafan results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17942926 |
| D013467 | Sulindac | AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein] | affects reaction|decreases expression | 18924134 |
| D013467 | Sulindac | [AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein]] which affects the susceptibility to Oxygen | affects reaction|affects response to substance|decreases expression | 18924134 |
| D013467 | Sulindac | Sulindac analog results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 18924134 |
| C025463 | sulindac sulfone | sulindac sulfone affects the phosphorylation of AKT1 protein | affects phosphorylation | 15570007 |
| C025463 | sulindac sulfone | [celecoxib co-treated with sulindac sulfone] results in decreased expression of AKT1 protein | affects cotreatment|decreases expression | 17908994 |
| C025463 | sulindac sulfone | [celecoxib co-treated with sulindac sulfone] results in decreased expression of AKT1 protein modified form | affects cotreatment|decreases expression | 17908994 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16021636 |
| D014284 | Triiodothyronine | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triiodothyronine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18096819 |
| D014284 | Triiodothyronine | AKT1 protein affects the reaction [Triiodothyronine affects the expression of TTN mRNA] | affects expression|affects reaction | 18096819 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased phosphorylation of AKT1 protein | increases phosphorylation | 18096819 16021636 |
| D013629 | Tamoxifen | Tamoxifen analog results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19549922 |
| D013629 | Tamoxifen | Tamoxifen results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 20549698 |
| D013629 | Tamoxifen | Tamoxifen results in increased activity of AKT1 protein | increases activity | 20372086 |
| D013629 | Tamoxifen | [Tamoxifen results in increased activity of AKT1 protein] which results in increased activity of MYC protein | increases activity | 20372086 |
| D013629 | Tamoxifen | [Tamoxifen results in increased activity of AKT1 protein] which results in increased activity of RPS6KB1 protein | increases activity | 20372086 |
| D013629 | Tamoxifen | TP53 protein inhibits the reaction [Tamoxifen results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 20549698 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of AKT1 mRNA | affects expression | 17555576 |
| D013629 | Tamoxifen | Tamoxifen results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 19393235 |
| D013656 | Taurocholic Acid | Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 12388182 |
| D013656 | Taurocholic Acid | wortmannin inhibits the reaction [Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in decreased phosphorylation of AKT1 protein]] | decreases phosphorylation|decreases reaction | 12388182 |
| D016593 | Terfenadine | 11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Terfenadine analog results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|decreases reaction | 19289568 |
| D016593 | Terfenadine | Terfenadine analog results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 19289568 |
| C004648 | testosterone enanthate | testosterone enanthate results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17440010 |
| D013749 | Tetrachlorodibenzodioxin | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 12668121 |
| D013749 | Tetrachlorodibenzodioxin | EGFR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of AKT1 protein] | increases activity|increases phosphorylation|increases reaction | 11309286 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of AKT1 protein | increases activity | 16051281 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 12668121 11309286 |
| D013749 | Tetrachlorodibenzodioxin | tyrphostin AG 1478 inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 11309286 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AKT1 mRNA | affects cotreatment|increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of AKT1 mRNA | increases expression | 17942748 |
| D013792 | Thalidomide | Thalidomide analog results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15858615 |
| D013792 | Thalidomide | Thalidomide analog results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15858615 |
| D019284 | Thapsigargin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Thapsigargin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15339911 |
| D019284 | Thapsigargin | Thapsigargin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 15339911 |
| D015244 | Thiorphan | [Thiorphan results in decreased activity of MME protein] which affects the activity of AKT1 protein | affects activity|decreases activity | 16405511 |
| D015244 | Thiorphan | Thiorphan results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16405511 |
| C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17015251 |
| D014028 | Tobacco Smoke Pollution | Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of AKT1 mRNA] | decreases reaction|increases expression | 16137721 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of AKT1 mRNA | increases expression | 16137721 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [IL1B protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17136479 |
| D014212 | Tretinoin | AKT1 protein inhibits the reaction [Tretinoin results in increased expression of RARB mRNA] | decreases reaction|increases expression | 16417524 |
| D014212 | Tretinoin | AKT1 protein promotes the reaction [Tretinoin results in increased expression of ITGAM protein] | increases expression|increases reaction | 16617325 |
| D014212 | Tretinoin | AKT1 protein results in decreased susceptibility to Tretinoin | decreases response to substance | 12556562 |
| D014212 | Tretinoin | geldanamycin inhibits the reaction [Tretinoin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17293044 |
| D014212 | Tretinoin | Tretinoin results in decreased activity of AKT1 protein | decreases activity | 16456186 |
| D014212 | Tretinoin | Tretinoin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17259349 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 17293044 16043647 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16617325 |
| D014212 | Tretinoin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16288212 |
| D014212 | Tretinoin | AKT1 protein inhibits the reaction [Tretinoin results in increased expression of RARB mRNA] | decreases reaction|increases expression | 16613989 |
| D014212 | Tretinoin | AKT1 protein inhibits the reaction [Tretinoin results in increased expression of TUBB3 protein] | decreases reaction|increases expression | 16613989 |
| D014212 | Tretinoin | PIK3R1 protein promotes the reaction [Tretinoin results in increased activity of AKT1 protein] | increases activity|increases reaction | 16288212 |
| D014212 | Tretinoin | Tretinoin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16288212 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of AKT1 protein | increases phosphorylation | 16288212 |
| C012589 | trichostatin A | AKT1 protein modified form results in decreased activity of [D 21266 co-treated with trichostatin A] | affects cotreatment|decreases activity | 15781658 |
| C012589 | trichostatin A | [D 21266 co-treated with trichostatin A] results in decreased activity of AKT1 protein | affects cotreatment|decreases activity | 15781658 |
| C447031 | tyrphostin AG 1024 | tyrphostin AG 1024 inhibits the reaction [P2RY1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16236484 |
| C447031 | tyrphostin AG 1024 | tyrphostin AG 1024 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16236484 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 11309286 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 11309286 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [TGFA protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 11309286 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15849355 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15849355 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Indomethacin results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17341418 |
| C113580 | U 0126 | U 0126 inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Paclitaxel results in increased activity of AKT1 protein] | decreases reaction|increases activity | 16211241 |
| C113580 | U 0126 | U 0126 inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15919668 |
| C113580 | U 0126 | U 0126 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18388193 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of AKT1 mRNA | increases expression | 19440698 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of AKT1 protein | increases expression | 19440698 |
| D014635 | Valproic Acid | Valproic Acid results in increased phosphorylation of AKT1 protein | increases phosphorylation | 19440698 |
| D014638 | Vanadates | Vanadates results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 14971663 |
| D014639 | Vanadium | PRKCA protein affects the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 14971662 |
| D014639 | Vanadium | PRKCI protein mutant form inhibits the reaction [Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 14971662 |
| D014639 | Vanadium | Vanadium results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 14971662 |
| C459559 | vaticanol C | vaticanol C results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 15725661 |
| C047426 | venlafaxine | venlafaxine results in increased expression of AKT1 protein | increases expression | 18511088 |
| D014750 | Vincristine | Vincristine promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16740780 |
| D014810 | Vitamin E | Vitamin E results in increased expression of AKT1 mRNA | increases expression | 19244175 |
| C111237 | vorinostat | AKT1 protein modified form results in decreased activity of [D 21266 co-treated with vorinostat] | affects cotreatment|decreases activity | 15781658 |
| C111237 | vorinostat | [D 21266 co-treated with vorinostat] results in decreased activity of AKT1 protein | affects cotreatment|decreases activity | 15781658 |
| C111237 | vorinostat | vorinostat results in decreased expression of AKT1 protein | decreases expression | 16144943 |
| C070417 | Win 55212-2 | CNR2 protein affects the reaction [Win 55212-2 results in increased phosphorylation of and results in increased activity of AKT1 protein] | affects reaction|increases activity|increases phosphorylation | 12734338 |
| C070417 | Win 55212-2 | Win 55212-2 results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 12734338 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Dehydroepiandrosterone results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16373398 |
| C009687 | wortmannin | wortmannin inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16373398 |
| C009687 | wortmannin | wortmannin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 12032135 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Histamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 11959800 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Neomycin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15800129 |
| C009687 | wortmannin | wortmannin inhibits the reaction [4-hydroxyestradiol-17 beta results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15050414 |
| C009687 | wortmannin | wortmannin inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased activity of and results in increased phosphorylation of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 19801633 |
| C009687 | wortmannin | wortmannin inhibits the reaction [C5 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16116186 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Copper results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Copper Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C009687 | wortmannin | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15608143 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Hexanones results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14757120 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Humic Substances results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 19686714 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Hydrocarbons, Chlorinated results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14757120 |
| C009687 | wortmannin | wortmannin inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16682453 17520698 |
| C009687 | wortmannin | wortmannin inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17550345 |
| C009687 | wortmannin | wortmannin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16116186 |
| C009687 | wortmannin | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15177934 |
| C009687 | wortmannin | wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 12482858 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| C009687 | wortmannin | wortmannin results in decreased activity of AKT1 protein | decreases activity | 12556562 |
| C009687 | wortmannin | wortmannin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 16059913 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Estradiol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15845746 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15178407 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17464197 |
| C009687 | wortmannin | wortmannin results in decreased expression of AKT1 protein | decreases expression | 15695173 17129604 |
| C009687 | wortmannin | wortmannin results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17129604 12032135 |
| C009687 | wortmannin | wortmannin inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15849355 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 18317400 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16825486 |
| C009687 | wortmannin | wortmannin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15849355 |
| C009687 | wortmannin | wortmannin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17962351 11306697 |
| C009687 | wortmannin | wortmannin inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 17346750 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in decreased phosphorylation of AKT1 protein]] | decreases phosphorylation|decreases reaction | 12388182 |
| C519885 | WP1066 | WP1066 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 18056455 |
| C087958 | YM 529 | YM 529 results in decreased phosphorylation of AKT1 protein | decreases phosphorylation | 17874104 |
| D015032 | Zinc | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Zinc results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| D015032 | Zinc | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| D015032 | Zinc | Zinc results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16973122 |
| D015032 | Zinc | AKT1 protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of GSK3B protein] | affects cotreatment|increases activity|increases phosphorylation|increases reaction | 17098228 |
| D015032 | Zinc | [Zinc co-treated with pyrithione] results in increased phosphorylation of and results in increased activity of AKT1 protein | affects cotreatment|increases activity|increases phosphorylation | 17098228 |
| D019287 | Zinc Sulfate | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Zinc Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| D019287 | Zinc Sulfate | wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 16973122 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein | increases activity|increases phosphorylation | 16973122 |
| C088658 | zoledronic acid | CYR61 protein affects the reaction [zoledronic acid results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | affects reaction|decreases activity|decreases phosphorylation | 19530242 |
| C088658 | zoledronic acid | zoledronic acid results in decreased phosphorylation of and results in decreased activity of AKT1 protein | decreases activity|decreases phosphorylation | 19530242 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 8.26 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 8.26 | 14745880 | |
| MESH:D015746 | Abdominal Pain | SU 5416 | 5.76 | 12673719 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Capsaicin | 12.25 | 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 12.25 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 12.25 | 15322242 11752688 14514962 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 12.25 | 8333272 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 12.25 | 8875741 | |
| MESH:D000015 | Abnormalities, Multiple | imatinib | 6.16 | 18322153 | |
| MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 6.16 | 19490988 | |
| MESH:D000022 | Abortion, Spontaneous | imatinib | 4.77 | 18322153 | |
| MESH:D000038 | Abscess | Drugs, Chinese Herbal | 4.87 | 15043669 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 9.78 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 9.78 | 11192467 | |
| MESH:D000138 | Acidosis | Zinc Sulfate | 9.78 | 7265320 | |
| MESH:D000142 | Acidosis, Respiratory | Copper Sulfate | 4.99 | 7265320 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 2.51 | 17505938 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.09 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 3.98 | 16889938 17190629 17202136 | |
| MESH:D058186 | Acute Kidney Injury | Capsaicin | 20.58 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 20.58 | 12690470 15814532 17670903 | |
| MESH:D058186 | Acute Kidney Injury | Gentamicins | 20.58 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | pifithrin | 20.58 | 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 20.58 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 20.58 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 20.58 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 14.66 | 20525806 21297076 | |
| MESH:D055371 | Acute Lung Injury | Chlorine | 14.66 | 20601635 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 14.66 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 14.66 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 14.66 | 18653653 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 4.07 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | 1,4-phenylenebis(methylene)selenocyanate | 28.65 | 12844480 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 28.65 | 11798837 19825857 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 28.65 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 28.65 | 17638652 11798837 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 28.65 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 28.65 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 28.65 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 28.65 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 28.65 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 28.65 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 28.65 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 28.65 | 15113128 15688392 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 28.65 | 11910360 | |
| MESH:D000230 | Adenocarcinoma | Vincristine | 28.65 | 19825857 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Tobacco Smoke Pollution | 4.09 | 15814487 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 12.88 | 10737359 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 12.88 | 6695378 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 12.88 | 6695378 10737359 | |
| MESH:D000236 | Adenoma | Indomethacin | 12.88 | 11497255 | |
| MESH:D000236 | Adenoma | resveratrol | 12.88 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 12.88 | 10223192 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.56 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 9.21 | 16434500 17162532 19052882 18056438 19061943 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 9.21 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 9.21 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | marker/mechanism | 17942926 | ||
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 25.72 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | dibenzoylmethane | 25.72 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Dinoprostone | 25.72 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Flurbiprofen | 25.72 | 10680582 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 25.72 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 25.72 | 19003578 11874996 11535846 15623613 12394442 16460482 17611924 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulindac sulfone | 25.72 | 16150858 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.26 | 15276417 | |
| MESH:D000309 | Adrenal Insufficiency | Dehydroepiandrosterone | 4.37 | 17302879 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 3.46 | 17306315 16712894 | |
| MESH:D000380 | Agranulocytosis | Clozapine | 3.66 | 16160616 14617031 12649775 | |
| MESH:D000382 | Agricultural Workers' Diseases | Atrazine | 4.40 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 4.40 | 11874814 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 6.92 | 21441931 | |
| MESH:D000419 | Albuminuria | Raloxifene | 6.92 | 17308373 17451421 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.88 | 15451039 15451040 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.64 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | Terfenadine | 4.34 | 16037679 | |
| MESH:D000505 | Alopecia | Capsaicin | 5.50 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 5.50 | 15955085 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.23 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 3.93 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 26.54 | 17570602 15207723 14715435 | |
| MESH:D000544 | Alzheimer Disease | bis(4-hydroxycinnamoyl)methane | 26.54 | 19090986 | |
| MESH:D000544 | Alzheimer Disease | Clioquinol | 26.54 | 16648635 17308104 | |
| MESH:D000544 | Alzheimer Disease | Copper | 26.54 | 17119284 16325427 16410023 16962711 16886094 16866297 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 26.54 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 26.54 | 17627676 15579461 | |
| MESH:D000544 | Alzheimer Disease | Iron | 26.54 | 16563566 16640825 | |
| MESH:D000544 | Alzheimer Disease | Lithium | 26.54 | 19621015 | |
| MESH:D000544 | Alzheimer Disease | Nicotine | 26.54 | 16627626 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 26.54 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 26.54 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 26.54 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 26.54 | 16183991 16162502 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 26.54 | 17119284 16580781 16325427 16410023 | |
| MESH:D000550 | Amblyopia | Valproic Acid | 3.79 | 17688650 | |
| MESH:D019969 | Amphetamine-Related Disorders | Amphetamine | 4.63 | 16916582 16459022 15010207 18475255 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 3.12 | 15469931 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 5.03 | 10694572 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 5.03 | 16510725 | |
| MESH:D000707 | Anaphylaxis | mangiferin | 4.08 | 16536907 14669257 | |
| MESH:D000740 | Anemia | Drugs, Chinese Herbal | 10.80 | 15504547 17963324 | |
| MESH:D000740 | Anemia | Fluorouracil | 10.80 | 15504547 17963324 16511603 | |
| MESH:D000740 | Anemia | Iron | 10.80 | 16434484 16566752 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 10.80 | 11748828 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 2.93 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 6.18 | 16614410 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 6.18 | 17375513 17147795 17163184 16569441 17162259 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.53 | 16916123 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 6.60 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | Manganese | 6.60 | 16910769 | |
| MESH:D000787 | Angina Pectoris | Drugs, Chinese Herbal | 3.99 | 11477813 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.41 | 10982225 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.43 | 15513904 | |
| MESH:D000855 | Anorexia | Amphetamine | 6.61 | 16101753 12183048 16084549 12005258 | |
| MESH:D000855 | Anorexia | oleoylethanolamide | 6.61 | 15879057 | |
| MESH:D000860 | Anoxia | Copper Sulfate | 10.84 | 7265320 | |
| MESH:D000860 | Anoxia | Oxygen | 10.84 | 20872349 | |
| MESH:D000860 | Anoxia | Zinc Sulfate | 10.84 | 7265320 | |
| MESH:D001004 | Anus Diseases | Drugs, Chinese Herbal | 4.52 | 15043669 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 4.93 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Valproic Acid | 4.93 | 17497229 | |
| MESH:D001014 | Aortic Aneurysm | Dinoprostone | 7.66 | 10231640 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 7.66 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 12.13 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Dinoprostone | 12.13 | 10388637 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 12.13 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 5.12 | 16604332 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 5.12 | 17460149 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 5.75 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 5.75 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.73 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 11.71 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 11.71 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Thalidomide | 11.71 | 9598899 | |
| MESH:D001169 | Arthritis, Experimental | Tosylphenylalanyl Chloromethyl Ketone | 11.71 | 18706406 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 11.71 | 16412693 | |
| MESH:D015210 | Arthritis, Gouty | Drugs, Chinese Herbal | 4.33 | 19655406 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 11.32 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 11.32 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | LY 117018 | 11.32 | 17907171 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 11.32 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | phenylmethylpyrazolone | 11.32 | 16390820 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tobacco Smoke Pollution | 11.32 | 19898480 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 11.32 | 16292516 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 7.03 | 16516891 | |
| MESH:D001249 | Asthma | Histamine | 7.03 | 16387687 | |
| MESH:D001249 | Asthma | Ozone | 7.03 | 16373670 17854713 | |
| MESH:D001249 | Asthma | Tretinoin | 7.03 | 16456186 | |
| MESH:D001249 | Asthma | Zinc | 7.03 | 17085522 | |
| MESH:D001259 | Ataxia | 1-Butanol | 4.24 | 7820390 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 8.41 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 8.41 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 18.10 | 17363696 16126721 16037261 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 18.10 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Cholesterol | 18.10 | 16632123 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 18.10 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 18.10 | 16632123 16640825 | |
| MESH:D050197 | Atherosclerosis | mangiferin | 18.10 | 18450471 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 18.10 | 16391483 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 18.10 | 16873680 17967414 | |
| MESH:D001284 | Atrophy | fulvestrant | 3.49 | 11514358 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Oxidopamine | 3.56 | 14699433 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 6.01 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Cysteine | 6.01 | 19056591 19267885 16917939 | |
| MESH:D001321 | Autistic Disorder | Docosahexaenoic Acids | 6.01 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 6.01 | 19267885 16917939 18929414 19056591 | |
| MESH:D001321 | Autistic Disorder | Haloperidol | 6.01 | 19368416 18080171 | |
| MESH:D001321 | Autistic Disorder | Iron | 6.01 | 17352947 | |
| MESH:D001321 | Autistic Disorder | Leuprolide | 6.01 | 17187010 | |
| MESH:D001321 | Autistic Disorder | Methionine | 6.01 | 16917939 19267885 19056591 | |
| MESH:D001321 | Autistic Disorder | olanzapine | 6.01 | 18685284 17069543 | |
| MESH:D001321 | Autistic Disorder | Sirolimus | 6.01 | 21115397 | |
| MESH:D001321 | Autistic Disorder | Valproic Acid | 6.01 | 20603192 17157402 18316065 19232924 18775368 19460635 18177632 17507914 18558336 17688650 18940202 18396377 16609825 18985861 15238991 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 14.61 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 14.61 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 14.61 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 14.61 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Iron | 3.78 | 16640825 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 3.03 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Dinoprostone | 8.08 | 15976003 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 8.08 | 10684365 | |
| MESH:D001714 | Bipolar Disorder | Lithium | 4.38 | 20338123 19153942 20046352 17594078 | |
| MESH:D001714 | Bipolar Disorder | Valproic Acid | 4.38 | 20046352 17594078 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 15.18 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | ferrous sulfate | 15.18 | 6421970 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 15.18 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 15.18 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 15.18 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.36 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 4.35 | 15746008 | |
| MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 4.35 | 8888407 | |
| MESH:D001851 | Bone Diseases, Metabolic | Ginkgo biloba extract 761 | 4.92 | 19356626 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 17.72 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 17.72 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 17.72 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 17.72 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | imatinib | 10.03 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 10.03 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 10.03 | 15867366 11697798 17312309 16121404 16778634 19442620 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 12.03 | 11985600 | |
| MESH:D001862 | Bone Resorption | Drugs, Chinese Herbal | 12.03 | 9881647 | |
| MESH:D001862 | Bone Resorption | mangiferin | 12.03 | 9881647 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 12.03 | 18496637 11869084 8053405 15845617 16769263 18404659 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 3.92 | 11207687 | |
| MESH:D001919 | Bradycardia | Capsaicin | 9.75 | 18207255 | |
| MESH:D001919 | Bradycardia | Isoproterenol | 9.75 | 6740701 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 9.75 | 15306635 | |
| MESH:D001929 | Brain Edema | Indomethacin | 3.59 | 11481608 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.89 | 17868700 | |
| MESH:D001930 | Brain Injuries | Progesterone | 10.49 | 15845082 15380490 15665606 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 10.49 | 16580743 | |
| MESH:D001930 | Brain Injuries | Zinc | 10.49 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Capsaicin | 12.92 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 12.92 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 12.92 | 12524144 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 12.92 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Copper | 17.61 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 17.61 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 17.61 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 17.61 | 16187019 | |
| MESH:D001932 | Brain Neoplasms | KCC 009 | 17.61 | 16170020 | |
| MESH:D001932 | Brain Neoplasms | monodansylcadaverine | 17.61 | 16170020 | |
| MESH:D001943 | Breast Neoplasms | marker/mechanism | 20228224 | ||
| MESH:D001943 | Breast Neoplasms | 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide | 57.29 | 20861237 | |
| MESH:D001943 | Breast Neoplasms | 4-hydroxyestradiol-17 beta | 57.29 | 16675129 | |
| MESH:D001943 | Breast Neoplasms | alitretinoin | 57.29 | 16344269 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 57.29 | 17132221 16541309 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 57.29 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 57.29 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Calcitriol | 57.29 | 11237771 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 57.29 | 19526202 18382427 | |
| MESH:D001943 | Breast Neoplasms | Copper | 57.29 | 15986119 17079463 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 57.29 | 18593918 16243823 19250217 18462866 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 57.29 | 18320071 19208741 | |
| MESH:D001943 | Breast Neoplasms | Deferoxamine | 57.29 | 15993339 | |
| MESH:D001943 | Breast Neoplasms | deguelin | 57.29 | 17035597 18593368 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 57.29 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 57.29 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 57.29 | 18234424 15136595 15993339 16595493 16826403 17426702 15692762 18695136 15994142 16264153 18382427 15634643 15668708 15567936 17983394 19526202 18628466 16935488 16115903 15939500 11325840 16322301 16096432 17369602 | |
| MESH:D001943 | Breast Neoplasms | equol | 57.29 | 16898868 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 57.29 | 12948864 17289903 16675129 19861407 14630087 17018787 17261762 18497071 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 57.29 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 57.29 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 57.29 | 16110121 19217205 18608205 16595493 16557594 15136595 18357371 | |
| MESH:D001943 | Breast Neoplasms | fulvestrant | 57.29 | 18984771 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 57.29 | 16541309 17200150 16873071 | |
| MESH:D001943 | Breast Neoplasms | Hexachlorobenzene | 57.29 | 15061365 12709520 | |
| MESH:D001943 | Breast Neoplasms | imatinib | 57.29 | 17614352 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 57.29 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 57.29 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | lapatinib | 57.29 | 16091755 | |
| MESH:D001943 | Breast Neoplasms | Linseed Oil | 57.29 | 21138602 | |
| MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 57.29 | 11306469 16253758 14633655 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 57.29 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | ochratoxin A | 57.29 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Organoselenium Compounds | 57.29 | 15833885 16155795 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 57.29 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 57.29 | 15136595 16273361 11325840 16244791 18223236 18323546 16115903 18234424 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 57.29 | 16175315 17614352 15562024 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 57.29 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 57.29 | 16837676 15758505 16912660 15572757 17595753 17893378 17242785 15775269 17440819 17049068 17952589 17261762 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 57.29 | 16393696 17651959 17534123 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 57.29 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 57.29 | 17261762 18821012 21152245 16273361 19011961 18984771 16873071 19059307 20859285 18855134 19200415 19103187 19288272 20065188 20390343 20005174 21138602 17242785 19084267 19244106 19410462 19289846 11161223 19142967 20544844 19487384 19189210 16818667 19115204 18425577 15565566 18351453 15668708 18997820 18629630 17049068 19155303 19066611 16202921 17440819 17893378 18815881 19189212 19221464 20135344 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 57.29 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 57.29 | 16873071 16443354 16166294 | |
| MESH:D001943 | Breast Neoplasms | Vanadium | 57.29 | 15565634 | |
| MESH:D001943 | Breast Neoplasms | vorinostat | 57.29 | 16144943 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 57.29 | 18695136 16096432 | |
| OMIM:604370 | BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 | marker/mechanism | |||
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 5.02 | 18417511 19059883 18315731 16777450 15516495 14754758 17626835 | |
| MESH:D016535 | Bronchial Hyperreactivity | tyrphostin AG 1478 | 5.02 | 12794006 | |
| MESH:D001986 | Bronchial Spasm | Histamine | 4.39 | 18298128 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.17 | 16813970 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 2.98 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 6.78 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 6.78 | 10459503 | |
| MESH:D002100 | Cachexia | Indomethacin | 7.71 | 15625704 16537180 11239499 15141370 | |
| MESH:D002100 | Cachexia | Ozone | 7.71 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.10 | 16962696 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.04 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 5.37 | 16050911 16124888 16192424 18705752 15700767 16097048 15673190 16011737 16227642 3786805 15721981 10355542 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 5.37 | 16050911 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 7.60 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 7.60 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 10.09 | 18593918 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 10.09 | 17121937 | |
| MESH:D002277 | Carcinoma | Hydrocarbons, Chlorinated | 10.09 | 12024805 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 10.09 | 16835633 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.11 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.71 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 53.11 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 53.11 | 6705139 3084413 10737359 17761372 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 53.11 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 53.11 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 53.11 | 16217749 15553829 11135700 14691202 15073043 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 53.11 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 53.11 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | deguelin | 53.11 | 18575727 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 53.11 | 17978847 11831363 20935162 16779866 18785209 21159647 20084675 19418558 3084413 20512989 19171122 19107877 19519916 19383236 10672840 19822196 19052882 19335982 19539802 19394651 17428255 18665156 17761372 17162532 17055752 10737359 16807293 18978308 17138121 20101231 16288022 20524982 18210153 16830150 20514400 16540662 19701751 20007298 18506893 18494052 17173139 16698587 3581430 19919837 18393292 20727157 19208518 16935385 18971187 18691550 16328049 16502159 20214788 20432363 16681979 16569478 16878318 18788625 18056438 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 53.11 | 15948411 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 53.11 | 16234567 17876044 16023760 18059187 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 53.11 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 53.11 | 15289165 15763234 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 53.11 | 17159502 16270382 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 53.11 | 18930000 17088986 16799960 17971768 17045692 16332177 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 53.11 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 53.11 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | morin | 53.11 | 19539802 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 53.11 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 53.11 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 53.11 | 16227395 19321006 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Sirolimus | 53.11 | 19335982 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 53.11 | 17306315 16507464 15276417 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 53.11 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 53.11 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 53.11 | 1917145 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Vanadium | 53.11 | 16830150 16878318 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.56 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 6.75 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 6.75 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 3.93 | 14736730 18791128 11352223 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bortezomib | 13.20 | 16052434 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 13.20 | 12023789 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 13.20 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | gefitinib | 13.20 | 15496427 16230376 20005069 19233551 18347146 17290066 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfone | 13.20 | 18758305 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Tobacco Smoke Pollution | 13.20 | 11212258 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 13.20 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.56 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.43 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 13.14 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 13.14 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 13.14 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 13.14 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | Vincristine | 13.14 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 13.14 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.82 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 42.16 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 42.16 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 42.16 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 42.16 | 17066447 6189445 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 42.16 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 42.16 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 42.16 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 42.16 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 42.16 | 16280240 18986760 16757204 17066447 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 42.16 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 42.16 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 42.16 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Sirolimus | 42.16 | 19435901 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 42.16 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tobacco Smoke Pollution | 42.16 | 11212258 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 42.16 | 16096774 16051514 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Vincristine | 42.16 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 42.16 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Amiloride | 8.63 | 14644129 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 8.63 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 8.63 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Copper | 16.83 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Doxazosin | 16.83 | 15969258 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 16.83 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Isoproterenol | 16.83 | 11179087 7544033 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 16.83 | 17124262 11179087 17287366 11754973 16170337 15728586 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 16.83 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 16.83 | 16120746 18850075 18670907 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 12.64 | 17329180 16455267 17131338 17007740 16109756 17308081 15505089 17519947 16364871 17924179 17351982 15476868 16651473 16612575 18627295 16242529 16731534 17974986 17382496 16952015 16269455 15792986 17928571 15811867 16278810 | |
| MESH:D009202 | Cardiomyopathies | H 2545 | 12.64 | 15613977 | |
| MESH:D009202 | Cardiomyopathies | Iron | 12.64 | 16640825 | |
| MESH:D009202 | Cardiomyopathies | sildenafil | 12.64 | 15811867 | |
| MESH:D009202 | Cardiomyopathies | Zalcitabine | 12.64 | 10591146 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 3.60 | 16243910 17334414 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 3.60 | 16604332 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 13.82 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 13.82 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 13.82 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 13.82 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 13.82 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 13.82 | 16936243 | |
| MESH:D002375 | Catalepsy | Haloperidol | 3.51 | 15215559 1977408 | |
| MESH:D002386 | Cataract | Acetaminophen | 9.12 | 10977129 | |
| MESH:D002386 | Cataract | Methylnitrosourea | 9.12 | 12484553 | |
| MESH:D002386 | Cataract | Simvastatin | 9.12 | 12518039 | |
| MESH:D002386 | Cataract | Tretinoin | 9.12 | 17460283 | |
| MESH:D002389 | Catatonia | olanzapine | 4.81 | 18071103 16772815 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4-hydroxyestradiol-17 beta | 31.06 | 18566989 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 31.06 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 31.06 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 31.06 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 31.06 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 31.06 | 2727394 7505956 21159647 17174075 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprostone | 31.06 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 31.06 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 31.06 | 7505956 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | monomethylarsonous acid | 31.06 | 19716837 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 31.06 | 20056578 19524636 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Vanadium | 31.06 | 17174075 | |
| MESH:D002543 | Cerebral Hemorrhage | phenylmethylpyrazolone | 4.44 | 19095969 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 8.28 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 8.28 | 16129372 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Methionine | 3.84 | 19267885 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 3.84 | 20734317 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 8.88 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 8.88 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thalidomide | 8.88 | 18291259 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.73 | 11181007 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 12.95 | 19486331 | |
| MESH:D002779 | Cholestasis | Diosgenin | 12.95 | 16105132 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 12.95 | 16105132 17333356 11677210 15861022 17681005 17110522 16919318 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 12.95 | 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 12.95 | 19176532 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.71 | 16461808 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.35 | 15894690 | |
| MESH:D016770 | Ciliophora Infections | Niclosamide | 4.33 | 12113305 | |
| MESH:D002971 | Cleft Lip | Ethanol | 2.63 | 15513904 | |
| MESH:D002972 | Cleft Palate | Ethanol | 4.75 | 15513904 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 4.75 | 12621046 8697196 15340226 16354765 15668235 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 4.75 | 9407595 | |
| MESH:D003072 | Cognition Disorders | Clozapine | 7.07 | 17123785 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 7.07 | 15800139 | |
| MESH:D003092 | Colitis | Amiloride | 24.09 | 12065299 | |
| MESH:D003092 | Colitis | Carbon Monoxide | 24.09 | 16365149 | |
| MESH:D003092 | Colitis | Curcumin | 24.09 | 16782535 18200517 16804969 | |
| MESH:D003092 | Colitis | resveratrol | 24.09 | 16474422 | |
| MESH:D003092 | Colitis | Selenium | 24.09 | 17936198 | |
| MESH:D003092 | Colitis | Thalidomide | 24.09 | 16680017 | |
| MESH:D003092 | Colitis | Tretinoin | 24.09 | 17035595 | |
| MESH:D003103 | Coloboma | Curcumin | 3.23 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | 1,4-phenylenebis(methylene)selenocyanate | 29.46 | 10753194 | |
| MESH:D003110 | Colonic Neoplasms | 17-(allylamino)-17-demethoxygeldanamycin | 29.46 | 15993848 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 29.46 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 29.46 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 29.46 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 29.46 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 29.46 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 29.46 | 17018589 18772588 16340194 16510598 17016597 17725105 17169374 15001691 17172411 17287894 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 29.46 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 29.46 | 15625704 15786552 11260862 15936596 15637740 15963497 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 29.46 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | oxaliplatin | 29.46 | 16510598 16004971 16024531 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 29.46 | 17148506 17191121 19440933 19056647 16640504 11134977 15741050 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 29.46 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 29.46 | 12458338 12902858 | |
| MESH:D003110 | Colonic Neoplasms | Vanadium | 29.46 | 18155637 | |
| MESH:D015179 | Colorectal Neoplasms | marker/mechanism | |||
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 19.97 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 19.97 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 19.97 | 18349538 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 19.97 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 19.97 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 19.97 | 18259882 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 19.97 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 19.97 | 20501625 17255274 16524972 14970324 16282729 18448328 18802399 17094418 16391804 18383874 17695437 16331619 17016601 15289873 17454858 17594712 17401013 16303861 18288408 18509181 18949393 15148649 | |
| MESH:D015179 | Colorectal Neoplasms | gefitinib | 19.97 | 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 19.97 | 17054584 12606626 18059344 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | oxaliplatin | 19.97 | 17401013 18448328 17695437 17255274 18509181 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 19.97 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 19.97 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 19.97 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 19.97 | 11076880 18059344 10666051 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | sulindac sulfone | 19.97 | 10666051 10416599 11197048 18059344 | |
| MESH:D003128 | Coma | Ginkgo biloba extract 761 | 4.79 | 10836866 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 1.81 | 17141729 14669216 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 7.99 | 18497527 | |
| MESH:D016510 | Corneal Neovascularization | Thalidomide | 7.99 | 9301478 | |
| MESH:D003327 | Coronary Disease | Fructose | 5.11 | 18504504 | |
| MESH:D003327 | Coronary Disease | resveratrol | 5.11 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.82 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.27 | 17302372 | |
| MESH:D003371 | Cough | Capsaicin | 3.76 | 10350223 | |
| MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 4.86 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 10.20 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 10.20 | 15513904 11198716 15451040 15451039 10194807 19302082 11873399 | |
| MESH:D019465 | Craniofacial Abnormalities | imatinib | 10.20 | 18322153 | |
| MESH:D019465 | Craniofacial Abnormalities | ochratoxin A | 10.20 | 20036863 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 10.20 | 20055451 15322242 10048152 | |
| MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 10.20 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 10.20 | 9664655 9224671 9125849 9142499 14991402 9211117 8800419 16925845 10589399 17551590 | |
| MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 10.20 | 8888407 16575769 17688650 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 10.20 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 10.20 | 19302082 | |
| MESH:D003424 | Crohn Disease | Thalidomide | 3.25 | 16078585 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 3.19 | 12952375 16002989 | |
| MESH:D003457 | Cryptosporidiosis | mangiferin | 4.42 | 16547730 | |
| MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 2.63 | 18551238 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 13.32 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Docosahexaenoic Acids | 13.32 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 13.32 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | sildenafil | 13.32 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Simvastatin | 13.32 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 3.97 | 12161096 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 8.51 | 16733453 | |
| MESH:D007644 | Darier Disease | Lithium | 8.51 | 20338123 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 6.47 | 15213294 | |
| MESH:D016757 | Death, Sudden, Cardiac | Haloperidol | 6.47 | 20210726 | |
| MESH:D003704 | Dementia | Haloperidol | 6.09 | 11575062 | |
| MESH:D003704 | Dementia | Methylmercury Compounds | 6.09 | 16140633 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.54 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 2.97 | 19031437 | |
| MESH:D003866 | Depressive Disorder | venlafaxine | 3.73 | 20305041 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 2.90 | 17474826 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cobaltous chloride | 2.92 | 15059100 11298694 16823706 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.56 | 18249437 | |
| MESH:D002658 | Developmental Disabilities | olanzapine | 3.60 | 17069543 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | 17-(allylamino)-17-demethoxygeldanamycin | 8.55 | 18854434 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | Lithium | 8.55 | 19244398 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 11.74 | 16640825 16604332 | |
| MESH:D003920 | Diabetes Mellitus | Metformin | 11.74 | 17446233 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 11.74 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 11.74 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Fructose | 9.85 | 18603373 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | mangiferin | 9.85 | 12093613 19028559 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 9.85 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 9.85 | 16873680 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Dehydroepiandrosterone | 3.73 | 16616286 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 3.73 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Clozapine | 17.91 | 16402076 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 17.91 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 17.91 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 17.91 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Fructose | 17.91 | 18603373 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 17.91 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 17.91 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | mangiferin | 17.91 | 11315760 9881663 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Metformin | 17.91 | 21186350 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 17.91 | 17107852 | |
| MESH:D003925 | Diabetic Angiopathies | Metformin | 4.65 | 16385087 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 18.83 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 18.83 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | mangiferin | 18.83 | 19706694 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 18.83 | 17451421 15920148 17308373 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 18.83 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 18.83 | 19279558 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.10 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 3.81 | 12861449 17621415 | |
| MESH:D003967 | Diarrhea | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 13.89 | 10611417 | |
| MESH:D003967 | Diarrhea | Dinoprostone | 13.89 | 10446763 11488427 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 13.89 | 7237001 7907874 | |
| MESH:D003967 | Diarrhea | SU 5416 | 13.89 | 12673719 | |
| MESH:D003967 | Diarrhea | Thiorphan | 13.89 | 3481337 | |
| MESH:D003967 | Diarrhea | vorinostat | 13.89 | 20479100 | |
| MESH:D006970 | Disorders of Excessive Somnolence | Clozapine | 4.11 | 15331141 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 19.98 | 18551238 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 19.98 | 10915739 16781746 14986274 12153990 11287661 19739265 11834606 14550746 19416960 14725611 16227642 12540782 11461765 10663392 18071297 11529661 17906064 16393943 17522070 12392966 11421492 11739529 12705907 19923254 12958197 18713872 10774834 16177239 11743745 15619225 16109766 15968718 19085960 12594235 17562736 19370779 16081117 2444490 19420014 19164858 16485898 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 19.98 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 19.98 | 16227642 19336974 21278145 7179309 7440962 10092053 10915739 2869522 19085960 15027814 16177239 11566570 4309450 6884620 15998439 9327722 3786805 15968718 17522070 6623471 3732212 7120509 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 19.98 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diquat | 19.98 | 18164269 18445702 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 19.98 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Drugs, Chinese Herbal | 19.98 | 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 19.98 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 19.98 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 19.98 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 19.98 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 19.98 | 19641884 1733752 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.66 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 16.95 | 12649298 19839026 15033597 12231392 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 16.95 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Gentamicins | 16.95 | 11033412 15033597 | |
| MESH:D004362 | Drug Toxicity | phenylmethylpyrazolone | 16.95 | 12231392 12649298 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 16.95 | 11462148 | |
| MESH:D004362 | Drug Toxicity | Zalcitabine | 16.95 | 7515130 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 3.73 | 17190690 18043480 18446180 12774134 16326151 16133044 | |
| MESH:D004381 | Duodenal Ulcer | Capsaicin | 7.75 | 11535926 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 7.75 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 7.75 | 17202747 10671773 17045617 11991626 11595431 17351913 11535926 11595415 17329845 17151854 16699067 | |
| MESH:D050171 | Dyslipidemias | Clozapine | 3.04 | 16402076 | |
| MESH:D004417 | Dyspnea | Chlorine | 13.04 | 20016425 | |
| MESH:D004417 | Dyspnea | Furosemide | 13.04 | 16935035 | |
| MESH:D004417 | Dyspnea | Oxygen | 13.04 | 20016425 | |
| MESH:D004417 | Dyspnea | SU 5416 | 13.04 | 12649163 12673719 | |
| MESH:D004421 | Dystonia | Valproic Acid | 2.72 | 1851702 | |
| MESH:D020821 | Dystonic Disorders | Nicotine | 4.50 | 17881519 | |
| MESH:C538011 | Eales disease | Vitamin E | 3.27 | 9068938 | |
| MESH:D004487 | Edema | bis(4-hydroxycinnamoyl)methane | 25.26 | 18449507 | |
| MESH:D004487 | Edema | bisindolylmaleimide I | 25.26 | 8273558 | |
| MESH:D004487 | Edema | demethoxycurcumin | 25.26 | 18449507 | |
| MESH:D004487 | Edema | Furosemide | 25.26 | 11834646 | |
| MESH:D004487 | Edema | imatinib | 25.26 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 25.26 | 19703484 7990266 7907874 10653021 16100529 8985016 8273558 | |
| MESH:D004487 | Edema | pirinixic acid | 25.26 | 12083418 | |
| MESH:D004487 | Edema | Raloxifene | 25.26 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 25.26 | 8985016 | |
| MESH:D004487 | Edema | Staurosporine | 25.26 | 8273558 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 25.26 | 12711302 11000095 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 7.19 | 15322242 16714409 18230668 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 7.19 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 22.70 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 22.70 | 15138306 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 22.70 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 22.70 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 22.70 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 22.70 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 22.70 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 9.27 | 19294695 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 9.27 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 7.21 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 7.21 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | 4-hydroxytamoxifen | 18.32 | 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 18.32 | 16804899 15700306 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 18.32 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 18.32 | 11473722 18566989 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 18.32 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 18.32 | 19155303 20544844 16202921 17893378 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 18.32 | 16569247 | |
| MESH:D004715 | Endometriosis | celecoxib | 19.23 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 19.23 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 19.23 | 16134523 | |
| MESH:D004715 | Endometriosis | Progesterone | 19.23 | 16134523 | |
| MESH:D004715 | Endometriosis | Sulindac | 19.23 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 19.23 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 3.72 | 18037988 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 9.70 | 18509659 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 9.70 | 15821434 17637181 15328337 | |
| MESH:D019446 | Endotoxemia | phenylmethylpyrazolone | 9.70 | 12954792 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.32 | 16328016 17763956 10567023 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 7.75 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 7.75 | 17923197 | |
| MESH:D004802 | Eosinophilia | Histamine | 7.50 | 12689652 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 7.50 | 11298111 | |
| MESH:D004802 | Eosinophilia | Pyrilamine | 7.50 | 1355641 | |
| MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 2.77 | 17275665 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Valproic Acid | 2.52 | 16628512 3922381 | |
| MESH:D004827 | Epilepsy | Valproic Acid | 2.04 | 20417680 18234410 | |
| MESH:D004832 | Epilepsy, Absence | Valproic Acid | 2.36 | 7562514 6426943 6254150 | |
| MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 2.91 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 2.67 | 3659116 | |
| MESH:D007172 | Erectile Dysfunction | sildenafil | 4.45 | 16368379 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.67 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Capsaicin | 4.28 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 17.99 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 17.99 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 17.99 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 17.99 | 17638652 16785472 16481741 15173087 15464296 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 17.99 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 17.99 | 17638652 15173087 16337965 16481741 16785472 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 17.99 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 17.99 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 17.99 | 12235107 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 17.99 | 16543248 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 4.87 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 4.87 | 9664655 16938888 | |
| MESH:D005221 | Fatigue | Amphetamine | 12.54 | 19890266 | |
| MESH:D005221 | Fatigue | SU 5416 | 12.54 | 12649163 12673719 | |
| MESH:D005221 | Fatigue | vorinostat | 12.54 | 20479100 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 62.58 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 62.58 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 62.58 | 16239168 61145 15959796 12631006 17595544 16045604 12795759 19224547 | |
| MESH:D005234 | Fatty Liver | Curcumin | 62.58 | 19297423 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 62.58 | 19224547 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 62.58 | 21071580 20387270 | |
| MESH:D005234 | Fatty Liver | Ethanol | 62.58 | 19236843 16409862 18620774 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 62.58 | 15345470 | |
| MESH:D005234 | Fatty Liver | Fish Oils | 62.58 | 18620774 | |
| MESH:D005234 | Fatty Liver | Fructose | 62.58 | 18641190 19196556 18395287 | |
| MESH:D005234 | Fatty Liver | Iron | 62.58 | 16640825 | |
| MESH:D005234 | Fatty Liver | mangiferin | 62.58 | 15975614 | |
| MESH:D005234 | Fatty Liver | phenylmethylpyrazolone | 62.58 | 12795759 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 62.58 | 20131406 19236843 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 62.58 | 17473493 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 62.58 | 14986274 19224547 | |
| MESH:D005234 | Fatty Liver | Valproic Acid | 62.58 | 14986274 19224547 | |
| MESH:D005234 | Fatty Liver | Zalcitabine | 62.58 | 18299183 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.22 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 4.63 | 16534752 16513791 16611131 16002989 15751030 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 4.63 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.40 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.88 | 15451040 16946407 10194807 15513904 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.08 | 11858732 | |
| MESH:D005315 | Fetal Diseases | Valproic Acid | 3.45 | 16575769 | |
| MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 2.77 | 8888407 18558336 | |
| MESH:D005334 | Fever | Dinoprostone | 8.03 | 11852909 16997862 | |
| MESH:D005334 | Fever | Indomethacin | 8.03 | 17627676 11852909 10431976 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 8.03 | 9205823 11852909 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 8.26 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 8.26 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 16.63 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | imatinib | 16.63 | 17453242 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 16.63 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 16.63 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 7.52 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 7.52 | 11555667 | |
| MESH:D005355 | Fibrosis | arsenite | 33.57 | 18296743 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 33.57 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 33.57 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 33.57 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Emodin | 33.57 | 19474275 | |
| MESH:D005355 | Fibrosis | Fructose | 33.57 | 18504504 | |
| MESH:D005355 | Fibrosis | Indomethacin | 33.57 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 33.57 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 33.57 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 33.57 | 17994277 | |
| MESH:D005393 | Fish Diseases | Niclosamide | 4.30 | 12113305 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.73 | 11298111 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 4.03 | 16604332 16640825 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.89 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Chlorine | 7.29 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 7.29 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 21.16 | 16983495 | |
| MESH:D005756 | Gastritis | Diquat | 21.16 | 15046732 | |
| MESH:D005756 | Gastritis | Ethanol | 21.16 | 15046732 | |
| MESH:D005756 | Gastritis | Indomethacin | 21.16 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 21.16 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.65 | 11910360 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.31 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 8.12 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 8.12 | 16452187 | |
| MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 4.86 | 12701121 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 2.80 | 8708960 | |
| MESH:D005909 | Glioblastoma | Capsaicin | 38.77 | 18405923 | |
| MESH:D005909 | Glioblastoma | Curcumin | 38.77 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 38.77 | 17150277 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 38.77 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 38.77 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 38.77 | 12870263 | |
| MESH:D005909 | Glioblastoma | KCC 009 | 38.77 | 16170020 | |
| MESH:D005909 | Glioblastoma | Manganese | 38.77 | 17043766 | |
| MESH:D005909 | Glioblastoma | monodansylcadaverine | 38.77 | 16170020 | |
| MESH:D005909 | Glioblastoma | Okadaic Acid | 38.77 | 17312396 | |
| MESH:D005909 | Glioblastoma | Quercetin | 38.77 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 38.77 | 17312396 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 38.77 | 18801729 | |
| MESH:D005910 | Glioma | Fluorouracil | 9.48 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 9.48 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Methylnitrosourea | 9.48 | 9825942 | |
| MESH:D005910 | Glioma | Quercetin | 9.48 | 17643826 | |
| MESH:D005910 | Glioma | Thalidomide | 9.48 | 16327979 | |
| MESH:D005911 | Gliosis | Paraquat | 3.72 | 11124998 | |
| MESH:D005922 | Glomerulonephritis, IGA | deoxynivalenol | 3.80 | 16524712 15173396 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 3.06 | 11849393 | |
| MESH:D018149 | Glucose Intolerance | Fructose | 3.98 | 19165636 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.15 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 3.93 | 11248219 | |
| MESH:D006130 | Growth Disorders | Amiloride | 5.35 | 19703807 | |
| MESH:D006130 | Growth Disorders | Zinc | 5.35 | 17217573 | |
| MESH:D006261 | Headache | Nitric Oxide | 6.98 | 11284996 11554966 | |
| MESH:D006261 | Headache | SU 5416 | 6.98 | 12649163 12673719 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 23.02 | 15102660 15464296 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 23.02 | 18829502 18462866 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 23.02 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 23.02 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 23.02 | 18337622 15162350 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 23.02 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Sirolimus | 23.02 | 19435901 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 23.02 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 9.41 | 19898482 | |
| MESH:D034381 | Hearing Loss | Furosemide | 9.41 | 17868369 | |
| MESH:D034381 | Hearing Loss | Gentamicins | 9.41 | 15968427 18024279 19130971 17868369 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.71 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.17 | 15464296 | |
| MESH:D006356 | Heartburn | Capsaicin | 4.28 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 10.54 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Lithium | 10.54 | 19638421 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 10.54 | 11294989 10048152 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 10.54 | 14991402 9664655 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 10.54 | 16080930 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 8.91 | 16244372 17888722 16879835 16330681 14766674 12587719 16495754 18674790 18006777 16144979 17875725 16244371 16707910 | |
| MESH:D006331 | Heart Diseases | mangiferin | 8.91 | 12093613 | |
| MESH:D006331 | Heart Diseases | pifithrin | 8.91 | 14766674 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 8.91 | 11110106 | |
| MESH:D006333 | Heart Failure | Dobutamine | 17.09 | 17440445 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 17.09 | 17481944 | |
| MESH:D006333 | Heart Failure | Furosemide | 17.09 | 16845234 12660669 16011733 | |
| MESH:D006333 | Heart Failure | Isoproterenol | 17.09 | 18097624 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 17.09 | 20558911 | |
| MESH:D006333 | Heart Failure | Selenium | 17.09 | 17162251 | |
| MESH:D006333 | Heart Failure | Zinc | 17.09 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.32 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 3.20 | 17241300 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 3.88 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 5.10 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 5.10 | 15692506 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.32 | 17053826 16574947 17255318 17236123 16640825 16604332 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.00 | 15720958 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.09 | 16366002 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.03 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.78 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.25 | 15633222 | |
| MESH:D006505 | Hepatitis | Caffeine | 8.22 | 11394713 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 8.22 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | Drugs, Chinese Herbal | 8.22 | 18339527 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.32 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 3.85 | 17338147 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 4.03 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 15.18 | 16607473 17276780 17182432 17109627 19888908 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 15.18 | 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 15.18 | 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc Sulfate | 15.18 | 17063115 | |
| MESH:D006529 | Hepatomegaly | GW0742 | 9.73 | 18593727 | |
| MESH:D006529 | Hepatomegaly | Iron | 9.73 | 16890145 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 9.73 | 16221962 19176532 18467677 19772884 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 9.73 | 12621046 15340226 16120746 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.64 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 2.00 | 16490937 16863852 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.59 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 8.59 | 10809021 | |
| MESH:D006561 | Herpes Simplex | mangiferin | 8.59 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 8.59 | 16876885 | |
| MESH:D015658 | HIV Infections | Iron | 4.14 | 16597321 | |
| MESH:D015658 | HIV Infections | Zalcitabine | 4.14 | 17457083 | |
| MESH:D019247 | HIV Wasting Syndrome | testosterone enanthate | 4.30 | 17440010 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 9.99 | 16170182 16200630 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 9.99 | 15147373 18501091 17606976 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 9.99 | 16200630 17606976 18180244 15147373 16135485 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 9.99 | 12676792 | |
| MESH:D006689 | Hodgkin Disease | Vincristine | 9.99 | 15147373 16794504 16135485 17606976 | |
| MESH:D019584 | Hot Flashes | Estradiol | 9.08 | 17088409 | |
| MESH:D019584 | Hot Flashes | venlafaxine | 9.08 | 14716179 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 9.08 | 14716179 | |
| MESH:D006849 | Hydrocephalus | Valproic Acid | 3.44 | 17688650 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.61 | 18606429 16959395 15340226 8697196 16354765 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 22.05 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Capsaicin | 22.05 | 17043245 17434803 | |
| MESH:D006930 | Hyperalgesia | Dinoprostone | 22.05 | 16793879 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 22.05 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 22.05 | 12727271 | |
| MESH:D006930 | Hyperalgesia | oxaliplatin | 22.05 | 17418472 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 22.05 | 16870215 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 22.05 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.27 | 17883296 | |
| MESH:D017588 | Hyperandrogenism | Metformin | 4.57 | 15356085 17062894 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.11 | 16899240 | |
| MESH:D006934 | Hypercalcemia | bortezomib | 10.78 | 18089816 | |
| MESH:D006934 | Hypercalcemia | Furosemide | 10.78 | 17652376 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 10.78 | 19622757 18089816 | |
| MESH:D053565 | Hypercalciuria | Furosemide | 8.76 | 17652376 | |
| MESH:D053565 | Hypercalciuria | Gentamicins | 8.76 | 17652376 | |
| MESH:D006937 | Hypercholesterolemia | Cholesterol | 11.34 | 16933029 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 11.34 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Pravastatin | 11.34 | 17188708 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 11.34 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 8.03 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 8.03 | 11156591 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.17 | 16778211 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 8.38 | 18262572 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 8.38 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 8.38 | 18262572 11834736 | |
| MESH:D020138 | Hyperhomocysteinemia | Catechin | 3.73 | 17292331 | |
| MESH:D006946 | Hyperinsulinism | Fructose | 6.34 | 18360027 19008412 14757778 18563319 15752949 | |
| MESH:D006946 | Hyperinsulinism | mangiferin | 6.34 | 9881663 11315760 | |
| MESH:D006948 | Hyperkinesis | Amphetamine | 7.13 | 1977408 14960337 | |
| MESH:D006948 | Hyperkinesis | Clozapine | 7.13 | 16046005 | |
| MESH:D006949 | Hyperlipidemias | Fish Oils | 18.92 | 15752949 | |
| MESH:D006949 | Hyperlipidemias | Fructose | 18.92 | 15752949 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 18.92 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | mangiferin | 18.92 | 15975614 | |
| MESH:D006949 | Hyperlipidemias | oleoylethanolamide | 18.92 | 15910890 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 18.92 | 16873680 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | Simvastatin | 4.00 | 16238680 | |
| MESH:D006962 | Hyperparathyroidism, Secondary | Furosemide | 4.43 | 15086907 | |
| MESH:D006963 | Hyperphagia | olanzapine | 4.81 | 17933447 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 3.06 | 14722030 12960047 | |
| MESH:D006967 | Hypersensitivity | Butylated Hydroxytoluene | 7.62 | 17604070 | |
| MESH:D006967 | Hypersensitivity | mangiferin | 7.62 | 16536907 | |
| MESH:D006967 | Hypersensitivity | Terfenadine | 7.62 | 2570798 | |
| MESH:D006968 | Hypersensitivity, Delayed | Fish Oils | 4.07 | 11484837 | |
| MESH:D006973 | Hypertension | Amiloride | 14.70 | 19344079 18524855 15174897 | |
| MESH:D006973 | Hypertension | Cyclosporine | 14.70 | 10903974 | |
| MESH:D006973 | Hypertension | Doxazosin | 14.70 | 15969258 | |
| MESH:D006973 | Hypertension | Fructose | 14.70 | 14568997 14573337 16843071 14633139 19008412 | |
| MESH:D006973 | Hypertension | Phenylephrine | 14.70 | 8949925 12717712 | |
| MESH:D006973 | Hypertension | Quercetin | 14.70 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 14.70 | 15787275 17577099 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 14.70 | 18670907 18850075 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 7.16 | 15338365 | |
| MESH:D006975 | Hypertension, Portal | ginkgolide B | 7.16 | 16409839 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Furosemide | 3.90 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | Copper Sulfate | 7.20 | 7265320 | |
| MESH:D006976 | Hypertension, Pulmonary | gefitinib | 7.20 | 18424623 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 7.20 | 15838368 | |
| MESH:D015228 | Hypertriglyceridemia | Fructose | 3.78 | 19342510 19799862 | |
| MESH:D006984 | Hypertrophy | Isoproterenol | 10.35 | 12791704 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 10.35 | 18502941 12791704 | |
| MESH:D006984 | Hypertrophy | Sirolimus | 10.35 | 19211884 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | phenylmethylpyrazolone | 6.48 | 15824197 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 6.48 | 17488730 | |
| MESH:D017380 | Hypertrophy, Right Ventricular | gefitinib | 4.81 | 18424623 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.75 | 12669777 | |
| MESH:D007006 | Hypogonadism | Iron | 3.26 | 16640825 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Amiloride | 4.43 | 19822448 | |
| MESH:C537153 | Hypomagnesemia primary | Furosemide | 4.23 | 11041285 | |
| MESH:D007019 | Hypoproteinemia | Furosemide | 4.43 | 16096441 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 6.63 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 6.63 | 16945680 16569931 | |
| MESH:D007022 | Hypotension | Furosemide | 7.89 | 11041285 | |
| MESH:D007022 | Hypotension | Isoproterenol | 7.89 | 6740701 | |
| MESH:D007022 | Hypotension | Zinc Sulfate | 7.89 | 7265320 | |
| MESH:D007024 | Hypotension, Orthostatic | Furosemide | 3.99 | 15811171 | |
| MESH:D007037 | Hypothyroidism | Iron | 3.69 | 16640825 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.59 | 10574470 18306037 | |
| MESH:D007079 | Ileitis | Indomethacin | 3.93 | 10647630 16133968 10651667 | |
| MESH:D007154 | Immune System Diseases | mangiferin | 4.42 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 3.93 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | pifithrin | 11.55 | 19475672 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 11.55 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 11.55 | 17600658 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 3.00 | 15036965 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.14 | 12013081 | |
| MESH:D007248 | Infertility, Male | Atrazine | 18.04 | 12948887 | |
| MESH:D007248 | Infertility, Male | decitabine | 18.04 | 17581917 | |
| MESH:D007248 | Infertility, Male | Diquat | 18.04 | 4850670 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 18.04 | 17937319 | |
| MESH:D007248 | Infertility, Male | fulvestrant | 18.04 | 11514358 | |
| MESH:D007248 | Infertility, Male | Methylnitrosourea | 18.04 | 7193160 | |
| MESH:D007248 | Infertility, Male | Paraquat | 18.04 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 18.04 | 15346721 12646999 | |
| MESH:D007249 | Inflammation | Amiloride | 32.61 | 17237260 | |
| MESH:D007249 | Inflammation | bisindolylmaleimide I | 32.61 | 8273558 | |
| MESH:D007249 | Inflammation | Capsaicin | 32.61 | 16956363 | |
| MESH:D007249 | Inflammation | Curcumin | 32.61 | 16956363 18403477 17151092 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 32.61 | 18785209 | |
| MESH:D007249 | Inflammation | Flurbiprofen | 32.61 | 11099482 | |
| MESH:D007249 | Inflammation | Indomethacin | 32.61 | 3291741 7812673 12568917 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 32.61 | 12878042 17237260 9205823 17255318 17963957 | |
| MESH:D007249 | Inflammation | mangiferin | 32.61 | 15222974 | |
| MESH:D007249 | Inflammation | Progesterone | 32.61 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 32.61 | 16366677 | |
| MESH:D007249 | Inflammation | Sulindac | 32.61 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 32.61 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 32.61 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Thalidomide | 32.61 | 16134734 | |
| MESH:D007249 | Inflammation | Tobacco Smoke Pollution | 32.61 | 18590791 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.43 | 18200517 18596194 | |
| MESH:D007251 | Influenza, Human | Quercetin | 15.08 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 15.08 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 15.08 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 15.08 | 16624496 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 18.11 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 18.11 | 16627594 16393666 | |
| MESH:D007333 | Insulin Resistance | Fructose | 18.11 | 17133782 19586609 14757778 18563319 19342510 14633139 19799862 18981581 18057795 19008412 14573337 | |
| MESH:D007333 | Insulin Resistance | mangiferin | 18.11 | 11315760 | |
| MESH:D007333 | Insulin Resistance | Metformin | 18.11 | 17062894 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 18.11 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 18.11 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 8.66 | 17329856 11713966 15831440 15610444 11855677 17994277 11686837 10210152 18236018 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 8.66 | 11574821 10210152 11713966 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 8.66 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | 1,4-phenylenebis(methylene)selenocyanate | 9.26 | 10753194 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 9.26 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 9.26 | 12584176 12628509 10223192 12351151 10213222 12663524 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 3.65 | 11245490 12394442 | |
| MESH:D002532 | Intracranial Aneurysm | phenylmethylpyrazolone | 4.02 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 3.93 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 7.13 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 7.13 | 17255318 | |
| MESH:D007511 | Ischemia | mangiferin | 14.70 | 16806951 | |
| MESH:D007511 | Ischemia | morin | 14.70 | 16806951 | |
| MESH:D007511 | Ischemia | phenylmethylpyrazolone | 14.70 | 16301206 | |
| MESH:D007511 | Ischemia | Zinc | 14.70 | 16584753 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 9.60 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 9.60 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 9.60 | 17551590 15992940 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.59 | 16133968 10574470 18306037 | |
| MESH:D007627 | Keloid | Quercetin | 3.56 | 17086741 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.00 | 15604871 | |
| MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.21 | 16144296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 8.57 | 15464296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Gentamicins | 8.57 | 18842672 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 49.48 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 49.48 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 49.48 | 16962696 16226777 16322080 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 49.48 | 16962696 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 49.48 | 18289764 12231392 19839026 15190930 12649298 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 49.48 | 10903974 8314463 18776723 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 49.48 | 15699352 16775033 15369732 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 49.48 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Furosemide | 49.48 | 11041285 | |
| MESH:D007674 | Kidney Diseases | Gentamicins | 49.48 | 18289764 17934191 19349640 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 49.48 | 17190690 | |
| MESH:D007674 | Kidney Diseases | mangiferin | 49.48 | 12093613 | |
| MESH:D007674 | Kidney Diseases | ochratoxin A | 49.48 | 11409539 | |
| MESH:D007674 | Kidney Diseases | phenylmethylpyrazolone | 49.48 | 18085390 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 49.48 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 49.48 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 49.48 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Zinc | 49.48 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 17.52 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 17.52 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 17.52 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 17.52 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 17.52 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 19.88 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 19.88 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 19.88 | 14681315 15003126 16762066 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 19.88 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 19.88 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | gefitinib | 19.88 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | ochratoxin A | 19.88 | 16251485 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 19.88 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Calcium | 11.62 | 16316344 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 11.62 | 11231351 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Gentamicins | 11.62 | 11231351 | |
| MESH:D007859 | Learning Disorders | Cholesterol | 15.61 | 17134702 | |
| MESH:D007859 | Learning Disorders | Copper | 15.61 | 17134702 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 15.61 | 17184923 | |
| MESH:D007859 | Learning Disorders | Ethanol | 15.61 | 15451040 | |
| MESH:D007859 | Learning Disorders | mangiferin | 15.61 | 19182383 | |
| MESH:D007889 | Leiomyoma | Curcumin | 6.70 | 18555241 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 6.70 | 16973256 | |
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 3.43 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Gentamicins | 7.08 | 10219319 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 7.08 | 11703811 12228301 10320625 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Zinc Sulfate | 7.08 | 15237267 | |
| MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 3.22 | 16514283 | |
| MESH:D007938 | Leukemia | 1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate | 21.27 | 12970779 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 21.27 | 12970779 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 21.27 | 15070760 | |
| MESH:D007938 | Leukemia | Curcumin | 21.27 | 18462866 | |
| MESH:D007938 | Leukemia | decitabine | 21.27 | 19235587 18980019 | |
| MESH:D007938 | Leukemia | Genistein | 21.27 | 17468513 18980019 | |
| MESH:D007938 | Leukemia | kaempferol | 21.27 | 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 21.27 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 21.27 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.72 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Drugs, Chinese Herbal | 4.51 | 15802533 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | fludarabine | 4.51 | 18587576 17802794 17658394 18172266 17296974 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 21.05 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | bortezomib | 21.05 | 18089816 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 21.05 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Docosahexaenoic Acids | 21.05 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Emodin | 21.05 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 21.05 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 16.67 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 16.67 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 16.67 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 16.67 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 10.46 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | imatinib | 10.46 | 15107311 19208803 17301526 15748426 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 10.46 | 16572323 15631656 10785260 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | mangiferin | 10.46 | 15498116 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 12.21 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 12.21 | 19117987 17236224 18454857 | |
| MESH:D007951 | Leukemia, Myeloid | imatinib | 12.21 | 17236224 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 12.21 | 16932348 19285840 16482212 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | 6,7-dimethoxy-3-phenylquinoxaline | 18.36 | 17050201 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 18.36 | 20471514 17050201 16467208 19850784 16968895 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | bortezomib | 18.36 | 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 18.36 | 17679729 18704418 19010910 19387464 18460780 18206229 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Deferoxamine | 18.36 | 20368581 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 18.36 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | SU 5416 | 18.36 | 12649163 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 18.36 | 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 18.36 | 16294345 17596541 19850784 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 18.36 | 18206229 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 18.36 | 17596541 16294345 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.02 | 18055864 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | marker/mechanism | 12556562 | ||
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 6.37 | 17869043 17107899 15213294 19035177 19225113 19642359 15622746 17649720 11161223 11468182 19075265 16112521 16966277 16823087 16891316 12018890 17217047 17712046 15748426 15336539 9834237 16330433 12712474 12679006 16331271 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 6.37 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 6.37 | 19035177 17506722 19225113 19075265 15748426 12679006 17217047 16891316 16766008 16788101 19642359 17361223 16140955 17712046 17368321 17649720 17107899 9834237 16331271 17294898 17301526 16823087 19029980 17339181 16935935 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.17 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.17 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 3.93 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.27 | 17980183 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 3.29 | 15821434 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.60 | 16707609 | |
| MESH:D020961 | Lewy Body Disease | Iron | 4.03 | 16563566 | |
| MESH:D056929 | Liddle Syndrome | Amiloride | 4.57 | 19344079 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 10.08 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 10.08 | 15526292 | |
| MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 10.08 | 10473037 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 10.08 | 9224671 | |
| MESH:D008064 | Lipidoses | Clozapine | 4.27 | 17567588 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 4.27 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.48 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.27 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 15.85 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 15.85 | 16239168 11408273 17334410 16943688 17174718 17157831 16221502 11903743 21278145 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 15.85 | 18665156 18407596 20032147 19638242 18522880 | |
| MESH:D008103 | Liver Cirrhosis | Drugs, Chinese Herbal | 15.85 | 17163593 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 15.85 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 15.85 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Thalidomide | 15.85 | 17174718 16943688 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.68 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 3.16 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 46.45 | 17944888 15052691 11481614 15959796 20821823 16027843 18006644 18263696 17698563 14716833 12546737 15996030 18705752 18395095 12898905 12609069 18277467 15123356 12649538 18420326 16638106 12445421 12445418 17640975 14716496 16011737 18317297 15876570 18481824 12741479 14724832 17976157 14620537 17565644 14748882 18418968 12632514 18205269 16015684 15362042 17823541 17525996 17557913 12667390 14512876 10355542 16136751 16033810 15730626 18339082 15673190 17721639 15370692 18279442 18472332 17900296 12389079 16097048 15931870 18429990 18054572 12586293 15057751 18156304 15893842 16192424 17481882 18412020 18166357 17631135 18472094 18376398 15650968 18210741 16116963 18251166 12666154 17714472 17869086 17805973 15925388 18187930 17922224 18395914 13678700 15338365 15818738 16248980 17766677 12632512 17708605 12958196 17761835 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 46.45 | 18705752 17355460 18006644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Cysteine | 46.45 | 15158331 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dinoprostone | 46.45 | 15816358 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 46.45 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Drugs, Chinese Herbal | 46.45 | 18371158 18606216 15641146 16610055 17036385 15339415 17666798 15744066 15849816 15754396 15763062 18567088 18237412 15818738 17881167 12632512 17629604 17348192 15864749 15383259 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Emodin | 46.45 | 15288473 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 46.45 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 46.45 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 46.45 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | farnesylthiosalicylic acid | 46.45 | 15288472 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | fasudil | 46.45 | 17761835 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 46.45 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Heparin | 46.45 | 16904936 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | imatinib | 46.45 | 16596278 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | inchinko-to | 46.45 | 15288473 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 46.45 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 46.45 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Methionine | 46.45 | 15158331 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | morin | 46.45 | 18629640 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 46.45 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 46.45 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Sirolimus | 46.45 | 17050028 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 46.45 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 46.45 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 46.45 | 15465738 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 46.45 | 16248980 18397230 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 46.45 | 16169303 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 15.26 | 12969438 16611625 19784758 16610002 19014921 19460945 11587558 12587719 | |
| MESH:D008107 | Liver Diseases | Capsaicin | 15.26 | 16956363 | |
| MESH:D008107 | Liver Diseases | Carbon Monoxide | 15.26 | 17173083 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 15.26 | 15830285 16246199 17285989 15720792 16964402 | |
| MESH:D008107 | Liver Diseases | Curcumin | 15.26 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 15.26 | 17034775 | |
| MESH:D008107 | Liver Diseases | Dinoprostone | 15.26 | 15816358 | |
| MESH:D008107 | Liver Diseases | Docosahexaenoic Acids | 15.26 | 17056761 | |
| MESH:D008107 | Liver Diseases | Drugs, Chinese Herbal | 15.26 | 17207593 | |
| MESH:D008107 | Liver Diseases | Sulindac | 15.26 | 14986274 16867024 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 6.89 | 17207112 17347304 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 6.89 | 17207112 16737972 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 2.78 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 8.96 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 8.96 | 16899240 14706259 | |
| MESH:D017114 | Liver Failure, Acute | venlafaxine | 8.96 | 19857765 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 37.79 | 14678523 18001218 10737359 16273603 11376686 10672840 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 37.79 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 37.79 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | Butylated Hydroxytoluene | 37.79 | 18177683 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 37.79 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Copper | 37.79 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | Dehydroepiandrosterone | 37.79 | 18709148 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 37.79 | 18977376 19256749 19642983 19833225 20118626 20452335 21071580 21047994 18978307 20492335 19294768 19426721 2862719 10737359 20101389 12771043 20501860 19499222 19254457 18754104 15175105 20405173 18648771 9163691 19427195 19812893 21167192 12112319 19073162 19690152 2422723 20137499 20583210 18644402 19255062 21278145 19551842 19638242 20434301 19850985 19996281 15885732 16942905 19090486 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 37.79 | 16712894 15890375 | |
| MESH:D008113 | Liver Neoplasms | Drugs, Chinese Herbal | 37.79 | 18339527 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 37.79 | 15113037 17045692 16603448 18383874 | |
| MESH:D008113 | Liver Neoplasms | Iron | 37.79 | 20302851 16640825 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 37.79 | 15890375 16377806 20007298 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 37.79 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 37.79 | 19812893 19073162 19321006 20405173 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 37.79 | 16712894 15276417 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 37.79 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 37.79 | 16984957 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 29.29 | 6150874 534488 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 29.29 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 29.29 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dehydroepiandrosterone | 29.29 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 29.29 | 9362446 3124819 19004024 18093689 19539802 18544905 19519916 17942915 19009564 18079962 16267830 18775883 17174075 18164116 18253720 18282651 18308698 16842330 2563599 21159647 17854601 19126423 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 29.29 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Hexachlorobenzene | 29.29 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | kojic acid | 29.29 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | morin | 29.29 | 19539802 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Organoselenium Compounds | 29.29 | 16170372 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 29.29 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 29.29 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vanadium | 29.29 | 17174075 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 9.76 | 15213294 | |
| MESH:D008133 | Long QT Syndrome | Dobutamine | 9.76 | 19353679 | |
| MESH:D008133 | Long QT Syndrome | olanzapine | 9.76 | 20210726 | |
| MESH:D008133 | Long QT Syndrome | Terfenadine | 9.76 | 8772706 | |
| MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 4.07 | 16080182 | |
| MESH:D008171 | Lung Diseases | 2-chloroethyl ethyl sulfide | 17.72 | 18675330 12815614 16252256 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 17.72 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 17.72 | 11504702 | |
| MESH:D008171 | Lung Diseases | Dobutamine | 17.72 | 16638327 | |
| MESH:D008171 | Lung Diseases | Ozone | 17.72 | 8266340 19066396 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 17.72 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 17.72 | 16863852 | |
| MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 2.84 | 17228818 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 13.96 | 17365036 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 13.96 | 21114838 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 13.96 | 11395602 | |
| MESH:D055370 | Lung Injury | Oxygen | 13.96 | 18339021 | |
| MESH:D055370 | Lung Injury | Ozone | 13.96 | 20417186 | |
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 43.19 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | alitretinoin | 43.19 | 16413115 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 43.19 | 11798837 19825857 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 43.19 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 43.19 | 18569708 17053015 18816296 20135361 20064080 20464547 20869020 6695378 18520028 | |
| MESH:D008175 | Lung Neoplasms | Butylated Hydroxytoluene | 43.19 | 16337739 19359593 15390079 19925653 18597497 11246140 11696405 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 43.19 | 6189445 11798837 17225452 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 43.19 | 16243823 18462866 19359593 | |
| MESH:D008175 | Lung Neoplasms | deguelin | 43.19 | 19336726 16288123 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 43.19 | 20512841 20970405 6695378 21163286 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 43.19 | 6189445 17418594 | |
| MESH:D008175 | Lung Neoplasms | Drugs, Chinese Herbal | 43.19 | 18339527 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 43.19 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Humic Substances | 43.19 | 19686714 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 43.19 | 11497255 11053908 16537180 | |
| MESH:D008175 | Lung Neoplasms | Iron | 43.19 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | mangiferin | 43.19 | 18520028 18816296 18569708 | |
| MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 43.19 | 18062963 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 43.19 | 8597069 7614698 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 43.19 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 43.19 | 17306315 19931552 16712894 17077188 15276417 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 43.19 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 43.19 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 43.19 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tobacco Smoke Pollution | 43.19 | 11091918 12111688 16288123 3440675 | |
| MESH:D008175 | Lung Neoplasms | Vincristine | 43.19 | 6189445 19825857 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 43.19 | 11062179 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.37 | 15086387 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.73 | 15166399 | |
| MESH:D008223 | Lymphoma | bortezomib | 24.89 | 16098063 | |
| MESH:D008223 | Lymphoma | Curcumin | 24.89 | 18462866 | |
| MESH:D008223 | Lymphoma | decitabine | 24.89 | 19470736 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 24.89 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 24.89 | 16098063 | |
| MESH:D008223 | Lymphoma | Etoposide | 24.89 | 12556972 12854902 | |
| MESH:D008223 | Lymphoma | Methylnitrosourea | 24.89 | 11418001 16257854 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 24.89 | 16166326 | |
| MESH:D008223 | Lymphoma | Zalcitabine | 24.89 | 8764131 8840982 18798262 9205081 17941976 11980663 9488045 | |
| MESH:D016393 | Lymphoma, B-Cell | bortezomib | 13.64 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 13.64 | 14633661 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 13.64 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 13.64 | 14737004 | |
| MESH:D017728 | Lymphoma, Large-Cell, Anaplastic | 17-(allylamino)-17-demethoxygeldanamycin | 5.19 | 17157164 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 7.48 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 7.48 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 7.48 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 6.96 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 6.96 | 15621674 | |
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous | vorinostat | 4.29 | 20479100 | |
| MESH:D008268 | Macular Degeneration | Iron | 3.00 | 16640825 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.07 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 5.37 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 5.37 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 1,4-phenylenebis(methylene)selenocyanate | 46.28 | 12844480 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Butylated Hydroxytoluene | 46.28 | 1500032 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 46.28 | 12104042 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Dehydroepiandrosterone | 46.28 | 16457693 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 46.28 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Drugs, Chinese Herbal | 46.28 | 14758024 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 46.28 | 16891317 17203775 11807958 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 46.28 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | gefitinib | 46.28 | 18375820 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 46.28 | 14578162 12929590 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 46.28 | 15688392 19196723 16944150 16827153 10838139 11807958 12931682 16051031 14999141 17131329 10767621 14633655 15313902 16619500 11751437 17020996 15113128 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | ochratoxin A | 46.28 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 46.28 | 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 46.28 | 8985016 11606380 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 46.28 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 46.28 | 19196722 11731420 16827153 14580682 19196723 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 46.28 | 12773700 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 46.28 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 14.16 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Manganese | 14.16 | 16568477 19453300 16551646 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 14.16 | 19453300 | |
| MESH:D008527 | Medulloblastoma | bortezomib | 4.07 | 19213072 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 4.07 | 17453147 | |
| MESH:D008545 | Melanoma | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 38.88 | 16077934 | |
| MESH:D008545 | Melanoma | aplidine | 38.88 | 18089842 | |
| MESH:D008545 | Melanoma | betulinic acid | 38.88 | 16077934 | |
| MESH:D008545 | Melanoma | Cisplatin | 38.88 | 16432458 12883367 12393984 17023156 18176117 18332650 18505091 17761969 16809738 12374674 16248763 11135225 15577323 | |
| MESH:D008545 | Melanoma | Curcumin | 38.88 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | decitabine | 38.88 | 16505122 17785578 | |
| MESH:D008545 | Melanoma | Doxorubicin | 38.88 | 16827129 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 38.88 | 17992120 11746506 | |
| MESH:D008545 | Melanoma | farnesylthiosalicylic acid | 38.88 | 12535206 | |
| MESH:D008545 | Melanoma | Fenretinide | 38.88 | 16270382 | |
| MESH:D008545 | Melanoma | Glucose | 38.88 | 14993021 | |
| MESH:D008545 | Melanoma | Histamine | 38.88 | 17709802 | |
| MESH:D008545 | Melanoma | Paclitaxel | 38.88 | 12040289 12025231 16342250 | |
| MESH:D008545 | Melanoma | resveratrol | 38.88 | 17992120 | |
| MESH:D008545 | Melanoma | Sirolimus | 38.88 | 19282848 | |
| MESH:D008545 | Melanoma | sodium arsenite | 38.88 | 16487513 19082730 | |
| MESH:D008545 | Melanoma | Sulindac | 38.88 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 38.88 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Thalidomide | 38.88 | 16098027 17089043 12829675 | |
| MESH:D008545 | Melanoma | Tretinoin | 38.88 | 16752155 | |
| MESH:D008545 | Melanoma | trichostatin A | 38.88 | 16505122 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 11.56 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 11.56 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Vincristine | 11.56 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 6.39 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 6.39 | 10803710 | |
| MESH:D008569 | Memory Disorders | Curcumin | 11.80 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 11.80 | 18411066 15451040 | |
| MESH:D008569 | Memory Disorders | mangiferin | 11.80 | 19182383 | |
| MESH:D008569 | Memory Disorders | Methylmercury Compounds | 11.80 | 18436314 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 3.03 | 16940565 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.46 | 17109627 17268249 | |
| MESH:D001523 | Mental Disorders | Clozapine | 10.23 | 16856516 | |
| MESH:D001523 | Mental Disorders | Haloperidol | 10.23 | 16856516 | |
| MESH:D001523 | Mental Disorders | olanzapine | 10.23 | 16856516 | |
| MESH:D001523 | Mental Disorders | Phosphates | 10.23 | 12686366 | |
| MESH:D001523 | Mental Disorders | venlafaxine | 10.23 | 16856516 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 12.73 | 16166281 16966607 18303189 | |
| MESH:D008654 | Mesothelioma | Atrazine | 12.73 | 1916698 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 12.73 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 12.73 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 12.73 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 12.73 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | olanzapine | 10.39 | 19142110 | |
| MESH:D008659 | Metabolic Diseases | phenylmethylpyrazolone | 10.39 | 16301206 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 10.39 | 17112576 | |
| MESH:D024821 | Metabolic Syndrome X | Clozapine | 5.90 | 19142101 | |
| MESH:D024821 | Metabolic Syndrome X | Fructose | 5.90 | 18497449 17098227 17261469 16815490 19165636 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.34 | 16801185 | |
| MESH:D008679 | Metaplasia | Ozone | 3.66 | 10496685 | |
| MESH:D008850 | Microphthalmos | ochratoxin A | 4.42 | 20036863 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 8.61 | 11903285 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 8.61 | 11701602 | |
| MESH:D008881 | Migraine Disorders | Valproic Acid | 8.61 | 18803445 18765137 | |
| MESH:D008881 | Migraine Disorders | venlafaxine | 8.61 | 18803445 | |
| MESH:D020326 | Migraine without Aura | Cyclic GMP | 10.24 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Dinoprostone | 10.24 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 10.24 | 14659530 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.17 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 4.11 | 15863610 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 18.11 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 18.11 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 18.11 | 16757204 18986760 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 18.11 | 12636206 | |
| MESH:D009062 | Mouth Neoplasms | Sirolimus | 18.11 | 19435901 | |
| MESH:D009062 | Mouth Neoplasms | Tobacco Smoke Pollution | 18.11 | 15006635 | |
| MESH:D009069 | Movement Disorders | Manganese | 7.16 | 16551646 | |
| MESH:D009069 | Movement Disorders | Methylmercury Compounds | 7.16 | 18436314 | |
| MESH:D052016 | Mucositis | Doxorubicin | 3.37 | 17415656 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 42.61 | 19417148 14977855 15949261 11468182 19549372 | |
| MESH:D009101 | Multiple Myeloma | bortezomib | 42.61 | 19372569 19112817 19112201 | |
| MESH:D009101 | Multiple Myeloma | Capsaicin | 42.61 | 17505005 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 42.61 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | CPS 11 | 42.61 | 15858615 | |
| MESH:D009101 | Multiple Myeloma | CPS 49 | 42.61 | 15858615 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 42.61 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 42.61 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 42.61 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 42.61 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 42.61 | 16267019 16490592 17164350 14749477 17049120 17935668 | |
| MESH:D009101 | Multiple Myeloma | Thalidomide | 42.61 | 15741222 17168659 19112817 15939924 15867202 19112201 15744524 16445831 15920492 19372569 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 42.61 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 42.61 | 18089719 16996129 19621390 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 4.23 | 17086897 | |
| MESH:D009128 | Muscle Spasticity | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 8.89 | 17220914 | |
| MESH:D009128 | Muscle Spasticity | Win 55212-2 | 8.89 | 17220914 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 13.03 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 13.03 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 13.03 | 17962980 | |
| MESH:D009135 | Muscular Diseases | GW0742 | 6.48 | 18593727 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 6.48 | 16239165 | |
| MESH:D009137 | Muscular Dystrophy, Animal | Gentamicins | 4.83 | 18694830 | |
| MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 2.71 | 8888407 | |
| MESH:D009181 | Mycoses | Iron | 4.03 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.23 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 15.41 | 16882451 16105982 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 15.41 | 19010910 19157545 18608210 16882708 | |
| MESH:D009190 | Myelodysplastic Syndromes | SU 5416 | 15.41 | 12649163 | |
| MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 15.41 | 18720364 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 15.41 | 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 15.41 | 17596541 | |
| MESH:D009196 | Myeloproliferative Disorders | WP1066 | 5.68 | 18245540 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 22.52 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 22.52 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Isoproterenol | 22.52 | 16584858 16538859 19595682 17052832 15740881 19172585 16697266 | |
| MESH:D009203 | Myocardial Infarction | Lithium | 22.52 | 16288908 | |
| MESH:D009203 | Myocardial Infarction | mangiferin | 22.52 | 16584858 17052832 16697266 16538859 19172585 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 22.52 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Pravastatin | 22.52 | 17188708 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 22.52 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 22.52 | 16456233 17125593 17015251 17188708 16317513 16525036 | |
| MESH:D009203 | Myocardial Infarction | Vincristine | 22.52 | 17284715 | |
| MESH:D017202 | Myocardial Ischemia | Dobutamine | 11.91 | 12447174 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 11.91 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 11.91 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 11.91 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 14.02 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 14.02 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 14.02 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 14.02 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 14.02 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.35 | 17322642 | |
| MESH:D009232 | Myxoma | Raloxifene | 4.11 | 16343187 | |
| MESH:D009325 | Nausea | vorinostat | 4.10 | 20479100 | |
| MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 2.47 | 18551238 | |
| MESH:D009361 | Neoplasm Invasiveness | Amiloride | 22.94 | 14644129 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 22.94 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | bis(4-hydroxycinnamoyl)methane | 22.94 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 22.94 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | demethoxycurcumin | 22.94 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Leuprolide | 22.94 | 17143537 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 16.84 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 16.84 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 16.84 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | imatinib | 16.84 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 16.84 | 11053908 11239499 16537180 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 16.84 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 16.84 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 16.84 | 17312309 19139120 15867366 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.84 | 19410462 | |
| MESH:D009369 | Neoplasms | Acrolein | 35.95 | 17329238 | |
| MESH:D009369 | Neoplasms | alitretinoin | 35.95 | 16946489 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 35.95 | 11141357 | |
| MESH:D009369 | Neoplasms | Cisplatin | 35.95 | 16773208 | |
| MESH:D009369 | Neoplasms | decitabine | 35.95 | 19470736 17925555 19116145 | |
| MESH:D009369 | Neoplasms | deguelin | 35.95 | 17764071 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 35.95 | 15313581 | |
| MESH:D009369 | Neoplasms | Fenretinide | 35.95 | 15958647 17353921 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 35.95 | 18239605 18600527 16928823 | |
| MESH:D009369 | Neoplasms | lycopene | 35.95 | 17051425 | |
| MESH:D009369 | Neoplasms | Methylnitrosourea | 35.95 | 15533788 | |
| MESH:D009369 | Neoplasms | Nicotine | 35.95 | 16365874 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 35.95 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 35.95 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 35.95 | 11559025 | |
| MESH:D009369 | Neoplasms | SU 5416 | 35.95 | 17264769 | |
| MESH:D009369 | Neoplasms | Tretinoin | 35.95 | 16946489 16594593 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 14.19 | 15625704 10663608 | |
| MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 14.19 | 12696579 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 14.19 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 14.19 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Zalcitabine | 14.19 | 9488045 8764131 9205081 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 14.62 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 14.62 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | imatinib | 14.62 | 17614352 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 14.62 | 19200415 19189210 19196722 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 12.92 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 12.92 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 12.92 | 17289903 | |
| MESH:D009389 | Neovascularization, Pathologic | Nicotine | 12.92 | 16365874 | |
| MESH:D009393 | Nephritis | Acrolein | 4.84 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 3.08 | 15464296 | |
| MESH:D009397 | Nephrocalcinosis | Furosemide | 4.43 | 15086907 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.37 | 16899518 16636307 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.00 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 8.50 | 18481113 19348381 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 8.50 | 15640375 16889571 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 8.50 | 17178036 | |
| MESH:D009410 | Nerve Degeneration | 1-Methyl-4-phenylpyridinium | 13.63 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | Manganese | 13.63 | 16551646 | |
| MESH:D009410 | Nerve Degeneration | mangiferin | 13.63 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 13.63 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 13.63 | 18619942 17356569 15790535 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 25.77 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 25.77 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 25.77 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 25.77 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 25.77 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Thalidomide | 25.77 | 16859833 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 25.77 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.19 | 18462866 | |
| MESH:D009437 | Neuralgia | Zalcitabine | 4.89 | 17292584 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 14.23 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 14.23 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | ochratoxin A | 14.23 | 20036863 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 14.23 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 14.23 | 9142499 | |
| MESH:D009436 | Neural Tube Defects | Valproic Acid | 14.23 | 8888407 16359493 | |
| MESH:D009442 | Neurilemmoma | Methylnitrosourea | 4.07 | 11555667 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 3.91 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 3.91 | 15555623 | |
| MESH:D019636 | Neurodegenerative Diseases | 1-Methyl-4-phenylpyridinium | 33.37 | 16353238 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 33.37 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 33.37 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Amphetamine | 33.37 | 15183010 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 33.37 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 33.37 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 33.37 | 17296847 16604332 | |
| MESH:D019636 | Neurodegenerative Diseases | Oxidopamine | 33.37 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 33.37 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 33.37 | 17266991 16850258 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 7.15 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Vincristine | 7.15 | 12837982 | |
| MESH:D020078 | Neurogenic Inflammation | Capsaicin | 10.20 | 17961222 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 10.20 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 10.20 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.67 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.25 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 2.35 | 16436463 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | Cholesterol | 4.31 | 20557099 9802331 | |
| MESH:D053206 | Nocturnal Enuresis | Furosemide | 4.43 | 17945291 | |
| MESH:D009669 | Nose Neoplasms | Hydrocarbons, Chlorinated | 4.31 | 12024805 | |
| MESH:D009765 | Obesity | 2-chloroethyl ethyl sulfide | 13.70 | 16289378 | |
| MESH:D009765 | Obesity | Capsaicin | 13.70 | 19056576 | |
| MESH:D009765 | Obesity | Clozapine | 13.70 | 18515891 19142110 | |
| MESH:D009765 | Obesity | Curcumin | 13.70 | 19297423 | |
| MESH:D009765 | Obesity | Fructose | 13.70 | 18585860 17707055 | |
| MESH:D009765 | Obesity | olanzapine | 13.70 | 18515891 | |
| MESH:D009765 | Obesity | oleoylethanolamide | 13.70 | 15910890 | |
| MESH:D009765 | Obesity | pirinixic acid | 13.70 | 20558911 | |
| MESH:D009771 | Obsessive-Compulsive Disorder | venlafaxine | 4.35 | 17503984 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.73 | 6374098 | |
| MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 2.17 | 16049721 12819281 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 4.46 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 4.46 | 16640825 | |
| MESH:D010005 | Osteoarthropathy, Secondary Hypertrophic | Dinoprostone | 5.03 | 18500342 | |
| MESH:D010014 | Osteolysis | imatinib | 12.34 | 15867366 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 12.34 | 15867366 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 12.34 | 15867366 | |
| MESH:D010024 | Osteoporosis | Calcium | 17.09 | 17882678 | |
| MESH:D010024 | Osteoporosis | Curcumin | 17.09 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 17.09 | 19401787 | |
| MESH:D010024 | Osteoporosis | Iron | 17.09 | 16648989 16640825 | |
| MESH:D010024 | Osteoporosis | kaempferol | 17.09 | 16756079 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 17.09 | 19059307 17882678 15775268 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 17.09 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Dehydroepiandrosterone | 27.20 | 16397352 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Drugs, Chinese Herbal | 27.20 | 16548355 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 27.20 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | LY 117018 | 27.20 | 17907171 17638036 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 27.20 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 27.20 | 15758505 17823083 17893378 15579764 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 27.20 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 2.89 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.56 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | marker/mechanism | 16211241 | ||
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 43.66 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | 43.66 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 43.66 | 19769630 12452020 16624393 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 43.66 | 17225452 19769630 6897625 15464296 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 43.66 | 19020741 18462866 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 43.66 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 43.66 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 43.66 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 43.66 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 43.66 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 43.66 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 43.66 | 17393432 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 43.66 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 43.66 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Thalidomide | 43.66 | 16288038 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 43.66 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 43.66 | 19331143 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 43.66 | 16211241 | |
| MESH:D010146 | Pain | marker/mechanism | 17084039 | ||
| MESH:D010146 | Pain | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 13.66 | 18987195 | |
| MESH:D010146 | Pain | Acetaminophen | 13.66 | 16870215 | |
| MESH:D010146 | Pain | Capsaicin | 13.66 | 16996476 17084039 17434803 19081190 18987195 17043245 | |
| MESH:D010146 | Pain | Indomethacin | 13.66 | 17627676 3291741 17440234 13679232 | |
| MESH:D010146 | Pain | Sulindac | 13.66 | 3291741 | |
| MESH:D010146 | Pain | Tretinoin | 13.66 | 16870215 | |
| MESH:D010146 | Pain | zoledronic acid | 13.66 | 16475674 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 3.26 | 12538197 18702446 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 33.03 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 33.03 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 33.03 | 17440100 19196508 19401701 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 33.03 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 33.03 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 33.03 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 33.03 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 33.03 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 33.03 | 16929163 15113037 19003803 16500647 | |
| MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 33.03 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 33.03 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 33.03 | 11504793 16820089 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 33.03 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 33.03 | 19294695 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 6.93 | 15028970 17883296 | |
| MESH:D010195 | Pancreatitis | phenylmethylpyrazolone | 6.93 | 20035747 | |
| MESH:D010195 | Pancreatitis | Taurocholic Acid | 6.93 | 20035747 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.35 | 11578682 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 5.16 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 5.16 | 12065085 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.82 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.27 | 16537180 | |
| MESH:D020447 | Parasomnias | Iron | 4.57 | 17352947 | |
| MESH:D010291 | Paresis | Thalidomide | 4.86 | 9200351 | |
| MESH:D010300 | Parkinson Disease | 1-Methyl-4-phenylpyridinium | 17.38 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 17.38 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Atrazine | 17.38 | 17218051 | |
| MESH:D010300 | Parkinson Disease | Iron | 17.38 | 16563566 16640825 | |
| MESH:D010300 | Parkinson Disease | Manganese | 17.38 | 11181820 | |
| MESH:D010300 | Parkinson Disease | mangiferin | 17.38 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 17.38 | 11124998 12911755 16510128 11445065 11181820 15824117 16140633 15451049 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 17.38 | 16140633 15451049 18619942 18191903 16412576 11535288 19232380 11445065 19114014 | |
| MESH:D010300 | Parkinson Disease | Sirolimus | 17.38 | 19682553 | |
| MESH:D010302 | Parkinson Disease, Secondary | Oxidopamine | 6.80 | 15893579 11771942 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 6.80 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 7.99 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Manganese | 7.99 | 16140633 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 7.99 | 15795934 15574749 18197244 15927086 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.27 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 2.81 | 12520081 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.73 | 11148446 | |
| MESH:D010518 | Periodontitis | Indomethacin | 7.65 | 17225004 | |
| MESH:D010518 | Periodontitis | mangiferin | 7.65 | 19026997 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 5.99 | 15464296 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Zalcitabine | 5.99 | 18606552 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 3.96 | 15687053 | |
| MESH:D010538 | Peritonitis | Ozone | 2.77 | 16369182 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 4.30 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.72 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 9.30 | 14722030 | |
| MESH:D010900 | Pituitary Diseases | Iron | 9.30 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 3.28 | 16977796 15687265 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.45 | 15087411 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 3.50 | 10923243 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 9.17 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 9.17 | 17638057 | |
| MESH:D011014 | Pneumonia | Butylated Hydroxytoluene | 15.13 | 11893704 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 15.13 | 11605937 12224865 | |
| MESH:D011014 | Pneumonia | Ozone | 15.13 | 18381685 18007984 18929643 | |
| MESH:D011014 | Pneumonia | Paraquat | 15.13 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 3.93 | 18573544 | |
| MESH:D011041 | Poisoning | Iron | 3.02 | 16604332 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Metformin | 6.67 | 15356085 17062894 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Simvastatin | 6.67 | 17105841 | |
| MESH:D011087 | Polycythemia Vera | WP1066 | 5.34 | 18245540 | |
| MESH:D011141 | Polyuria | Furosemide | 4.23 | 17945291 | |
| MESH:D017499 | Porokeratosis | alitretinoin | 4.56 | 16144296 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Hexachlorobenzene | 10.94 | 9918132 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 10.94 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 10.94 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 8.02 | 12371664 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 8.02 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 8.02 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | imatinib | 6.90 | 12476293 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 6.90 | 17031469 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Vincristine | 6.90 | 21297632 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 5.52 | 16640825 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 5.52 | 17114810 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.73 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 20.14 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 20.14 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Methylmercury Compounds | 20.14 | 18436314 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 20.14 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 20.14 | 11399792 11896295 11222880 11118676 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 20.14 | 20603192 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 7.81 | 17616702 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 7.81 | 17616702 | |
| MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 3.36 | 15572423 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 6.17 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 6.17 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 15682402 | ||
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 31.79 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 31.79 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 31.79 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | bicalutamide | 31.79 | 18487222 19240160 17914592 19011039 15638997 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 31.79 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 31.79 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | Calcitriol | 31.79 | 18247401 16644109 16289102 12479363 15754350 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 31.79 | 17908994 15570007 | |
| MESH:D011471 | Prostatic Neoplasms | Clioquinol | 31.79 | 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 31.79 | 17308104 17079463 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 31.79 | 15129424 18156803 10851300 12497104 11398177 18226269 18769126 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 31.79 | 15046698 15846301 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 31.79 | 18437689 15897917 15749863 16888761 16729912 16868541 | |
| MESH:D011471 | Prostatic Neoplasms | equol | 31.79 | 16898868 16925846 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 31.79 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 31.79 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | farnesylthiosalicylic acid | 31.79 | 16780807 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 31.79 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 31.79 | 18626508 19082440 | |
| MESH:D011471 | Prostatic Neoplasms | Flurbiprofen | 31.79 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | gefitinib | 31.79 | 17914592 15651060 16685379 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 31.79 | 15256057 16925846 15378649 | |
| MESH:D011471 | Prostatic Neoplasms | Leuprolide | 31.79 | 17143537 | |
| MESH:D011471 | Prostatic Neoplasms | lycopene | 31.79 | 17337101 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 31.79 | 15682402 12376480 | |
| MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 31.79 | 16205645 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 31.79 | 17136230 16729912 17172428 16356831 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 31.79 | 17292933 14715546 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 31.79 | 16536755 15731164 16220300 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 31.79 | 17675339 17804756 16731767 17636462 15767336 17718901 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 31.79 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 31.79 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | sulindac sulfone | 31.79 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 31.79 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Thalidomide | 31.79 | 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 31.79 | 19789329 18798265 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 31.79 | 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | vorinostat | 31.79 | 17218635 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 31.79 | 16606632 16517595 12429649 16700911 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 31.79 | 12438248 19103299 | |
| MESH:D011507 | Proteinuria | Gentamicins | 7.96 | 15033597 | |
| MESH:D011507 | Proteinuria | Indomethacin | 7.96 | 11849393 | |
| MESH:D011507 | Proteinuria | Tretinoin | 7.96 | 16636307 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.57 | 16640825 | |
| MESH:D011536 | Prurigo | Thalidomide | 4.86 | 12755975 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 1.95 | 16919318 15861022 | |
| MESH:D019310 | Pseudolymphoma | Valproic Acid | 3.11 | 11422049 12752131 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 1.53 | 16882103 | |
| MESH:D011595 | Psychomotor Agitation | Haloperidol | 7.21 | 11575062 | |
| MESH:D011595 | Psychomotor Agitation | olanzapine | 7.21 | 18685284 | |
| MESH:D011618 | Psychotic Disorders | Clozapine | 5.28 | 15331141 | |
| MESH:D011618 | Psychotic Disorders | Haloperidol | 5.28 | 11575062 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.37 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.37 | 10548101 | |
| MESH:D011654 | Pulmonary Edema | Isoproterenol | 3.84 | 10903255 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.23 | 19168576 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 6.41 | 17975199 17322281 17365031 15814490 | |
| MESH:D011658 | Pulmonary Fibrosis | Drugs, Chinese Herbal | 6.41 | 16987627 | |
| MESH:D011658 | Pulmonary Fibrosis | gefitinib | 6.41 | 18424623 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 6.41 | 17997886 16324872 | |
| MESH:D011693 | Purpura | Raloxifene | 4.11 | 15770314 | |
| MESH:D011833 | Radiation Injuries, Experimental | mangiferin | 4.96 | 15830843 | |
| MESH:D012003 | Rectal Fistula | Drugs, Chinese Herbal | 4.52 | 15043669 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.75 | 18286688 18722050 15538739 16160472 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 13.28 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 13.28 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 13.28 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Gentamicins | 13.28 | 17132701 15728788 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.14 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Capsaicin | 10.44 | 18460982 19211983 | |
| MESH:D015427 | Reperfusion Injury | Furosemide | 10.44 | 16526316 | |
| MESH:D015427 | Reperfusion Injury | phenylmethylpyrazolone | 10.44 | 16041266 15629865 16753835 15086910 15948865 14654979 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 10.44 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 10.44 | 17058453 17520802 16317513 15827377 16314181 | |
| MESH:D012120 | Respiration Disorders | Chlorine | 3.78 | 18579056 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | 2-chloroethyl ethyl sulfide | 18.24 | 18257742 12210543 16292752 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 18.24 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 18.24 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Furosemide | 18.24 | 12394941 16096441 15912074 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 18.24 | 18339021 17627322 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 18.24 | 11700416 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 2.65 | 10835634 | |
| MESH:D012135 | Respiratory Sounds | Atrazine | 8.35 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 8.35 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Tobacco Smoke Pollution | 8.35 | 18410779 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.46 | 18990726 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.36 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 11.66 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 11.66 | 18172121 18155124 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 11.66 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 11.66 | 16584753 | |
| MESH:D012173 | Retinitis | Gentamicins | 4.83 | 18644591 | |
| MESH:D012175 | Retinoblastoma | Methylnitrosourea | 4.07 | 11555667 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 10.79 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 10.79 | 16116481 16283617 | |
| MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 10.79 | 19155313 | |
| MESH:D012220 | Rhinitis | Histamine | 3.75 | 12689652 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Drugs, Chinese Herbal | 7.25 | 15015336 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Terfenadine | 7.25 | 8201490 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.13 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 5.30 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 5.30 | 15675481 17203757 18313854 17710206 15625365 16767912 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 28.09 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 28.09 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 28.09 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 28.09 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 28.09 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | NVP ADW742 | 28.09 | 16740780 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 28.09 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.37 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.10 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 4.08 | 9673227 | |
| MESH:D012559 | Schizophrenia | marker/mechanism | 14745448 | ||
| MESH:D012559 | Schizophrenia | Clozapine | 6.80 | 20452607 17726453 18806925 11763009 17123785 20521326 11151749 20580759 20168265 18855531 19369910 16141801 20521320 17667964 20107430 | |
| MESH:D012559 | Schizophrenia | Copper | 6.80 | 16842975 | |
| MESH:D012559 | Schizophrenia | Haloperidol | 6.80 | 19369910 1830565 20107430 18513383 | |
| MESH:D012559 | Schizophrenia | Methionine | 6.80 | 15737665 | |
| MESH:D012559 | Schizophrenia | olanzapine | 6.80 | 20521326 17726453 20107430 | |
| MESH:D012559 | Schizophrenia | Valproic Acid | 6.80 | 15737665 19110320 | |
| MESH:D019873 | Schnitzler Syndrome | Thalidomide | 4.52 | 16096327 | |
| MESH:D012640 | Seizures | 2,4-dinitrotoluene | 7.12 | 18551238 | |
| MESH:D012640 | Seizures | Ethanol | 7.12 | 9754883 | |
| MESH:D012640 | Seizures | Lithium | 7.12 | 19660546 | |
| MESH:D012640 | Seizures | Nicotine | 7.12 | 17873105 | |
| MESH:D012640 | Seizures | Valproic Acid | 7.12 | 16876388 11044598 14763951 3137016 15475178 1511512 17978042 11738929 | |
| MESH:D018805 | Sepsis | Curcumin | 2.85 | 18389075 | |
| MESH:D012772 | Shock, Septic | mangiferin | 3.84 | 15177305 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 3.30 | 7327846 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Heparin | 4.66 | 12269725 | |
| MESH:D012871 | Skin Diseases | monomethylarsonous acid | 3.13 | 17431481 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 3.13 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 31.00 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | deguelin | 31.00 | 16041863 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 31.00 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 31.00 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Glucose | 31.00 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 31.00 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 31.00 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Okadaic Acid | 31.00 | 12628509 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 31.00 | 8985016 15837718 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 31.00 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 31.00 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tobacco Smoke Pollution | 31.00 | 18590791 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 31.00 | 16467112 | |
| MESH:D012893 | Sleep Disorders | Caffeine | 3.92 | 19395429 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Caffeine | 3.71 | 17225163 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.90 | 15464296 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.18 | 17203757 15625365 16767912 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 11.92 | 16709447 16002989 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 11.92 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 11.92 | 16709447 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 6.21 | 16503802 15862959 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 6.21 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 5.51 | 12854658 | |
| MESH:D016135 | Spinal Dysraphism | Valproic Acid | 5.51 | 19490988 | |
| MESH:D013226 | Status Epilepticus | Lithium | 7.91 | 19951488 19430551 19570321 | |
| MESH:D013226 | Status Epilepticus | Valproic Acid | 7.91 | 12833885 | |
| MESH:D019956 | Stereotypic Movement Disorder | Amphetamine | 4.98 | 1977408 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 9.49 | 18545984 17207306 16280098 10486359 17638125 10215738 16113693 15472012 15038085 17160473 18209964 10192188 16184426 | |
| MESH:D013272 | Stomach Diseases | phosphoramidon | 9.49 | 16280098 | |
| MESH:D013272 | Stomach Diseases | sildenafil | 9.49 | 16113693 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 21.33 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 21.33 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 21.33 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 21.33 | 15958060 17522103 18396642 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 21.33 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 21.33 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Docosahexaenoic Acids | 21.33 | 19015929 | |
| MESH:D013274 | Stomach Neoplasms | Drugs, Chinese Herbal | 21.33 | 18339527 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 21.33 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 21.33 | 17522103 19015929 16424979 16951190 17172411 17498489 15786421 18396642 19084572 18567086 | |
| MESH:D013274 | Stomach Neoplasms | Folfox protocol | 21.33 | 18505590 | |
| MESH:D013274 | Stomach Neoplasms | Furosemide | 21.33 | 17052386 | |
| MESH:D013274 | Stomach Neoplasms | imatinib | 21.33 | 15786421 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 21.33 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 21.33 | 18593901 16257854 15930296 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 21.33 | 18506536 18396642 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 21.33 | 17261132 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 20.65 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | bis(4-hydroxycinnamoyl)methane | 20.65 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 20.65 | 19188055 16631530 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 20.65 | 9211565 11906479 16755016 17918041 17189318 9562338 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 20.65 | 17657623 17135157 18181030 16755016 12467913 18237397 14567935 17627676 16169175 18431645 12498302 15138204 11595431 12077510 18193104 1323529 11729361 15104355 18299717 11145282 18087811 18543354 11595415 10750652 16934674 16397915 17918041 16150113 17977527 12500499 18726076 11523592 17895592 16252198 12787963 10423059 17654042 15255614 16631530 10878458 11906479 18209962 | |
| MESH:D013276 | Stomach Ulcer | mangiferin | 20.65 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 20.65 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | phosphoramidon | 20.65 | 11145282 | |
| MESH:D013276 | Stomach Ulcer | Thalidomide | 20.65 | 15138204 | |
| MESH:D020521 | Stroke | Acrolein | 7.50 | 16269634 | |
| MESH:D020521 | Stroke | Raloxifene | 7.50 | 16837676 | |
| MESH:D020521 | Stroke | Vitamin E | 7.50 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.18 | 16321402 | |
| MESH:D013345 | Subarachnoid Hemorrhage | Drugs, Chinese Herbal | 8.92 | 17634840 | |
| MESH:D013345 | Subarachnoid Hemorrhage | pifithrin | 8.92 | 18364113 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.61 | 16684133 16045194 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 2.98 | 9754883 | |
| MESH:D013398 | Sudden Infant Death | Iron | 8.62 | 16640825 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 8.62 | 12563064 | |
| MESH:D015173 | Supratentorial Neoplasms | Vincristine | 4.46 | 12837982 | |
| MESH:D017180 | Tachycardia, Ventricular | Haloperidol | 6.45 | 20210726 | |
| MESH:D017180 | Tachycardia, Ventricular | olanzapine | 6.45 | 20210726 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 3.41 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Capsaicin | 4.29 | 17997062 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.29 | 15464296 17225452 | |
| MESH:D013921 | Thrombocytopenia | Heparin | 9.06 | 16893407 16651880 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 9.06 | 15821434 | |
| MESH:D013921 | Thrombocytopenia | vorinostat | 9.06 | 20479100 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.28 | 11994571 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 8.32 | 15669648 | |
| MESH:D013927 | Thrombosis | Heparin | 8.32 | 16893407 | |
| MESH:D013927 | Thrombosis | SU 5416 | 8.32 | 12649163 | |
| MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 3.82 | 11418001 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.47 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 29.48 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 29.48 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 29.48 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 29.48 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 29.48 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 29.48 | 17909728 16010429 | |
| MESH:D013964 | Thyroid Neoplasms | gefitinib | 29.48 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | imatinib | 29.48 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 29.48 | 14736730 11352223 18791128 | |
| MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 29.48 | 3078959 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 29.48 | 17045167 16026305 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 8.95 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 8.95 | 19048282 | |
| OMIM:188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO | Nicotine | 3.56 | 16785264 11259349 16720336 | |
| MESH:D014029 | Tobacco Use Disorder | Nicotine | 4.06 | 15735609 18305452 17979512 18041664 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 13.14 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 13.14 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 13.14 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 13.14 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 9.54 | 15213294 | |
| MESH:D016171 | Torsades de Pointes | Dobutamine | 9.54 | 19353679 | |
| MESH:D016171 | Torsades de Pointes | Terfenadine | 9.54 | 8256756 | |
| MESH:D014178 | Translocation, Genetic | Valproic Acid | 3.79 | 17262798 | |
| MESH:D014235 | Trichinellosis | mangiferin | 4.62 | 14669257 | |
| MESH:D014376 | Tuberculosis | Iron | 4.58 | 16597321 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 4.58 | 16040207 | |
| MESH:D014402 | Tuberous Sclerosis | everolimus | 8.26 | 18495876 | |
| MESH:D014402 | Tuberous Sclerosis | Sirolimus | 8.26 | 18495876 21115397 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.48 | 10574470 17380554 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.11 | 3119515 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 36.73 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 36.73 | 1399818 15867355 15289314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 36.73 | 12845720 11780464 12973940 20435036 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 36.73 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 36.73 | 15464296 12973940 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 36.73 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 36.73 | 17616700 19087683 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 36.73 | 17306315 16452187 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 36.73 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 36.73 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | monomethylarsonous acid | 36.73 | 20375083 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 36.73 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 36.73 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 36.73 | 11723127 16452187 16712894 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 36.73 | 8653321 16712894 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tobacco Smoke Pollution | 36.73 | 12846360 | |
| MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.24 | 8888407 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.84 | 18462866 | |
| MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 2.90 | 10091137 | |
| MESH:D014581 | Urticaria | Acetaminophen | 7.47 | 10982225 | |
| MESH:D014581 | Urticaria | Histamine | 7.47 | 18298128 | |
| MESH:D014581 | Urticaria | Terfenadine | 7.47 | 2859714 2569995 2565098 2568013 2885854 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 25.08 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 25.08 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 25.08 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 25.08 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 25.08 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 25.08 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 25.08 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 9.05 | 14652134 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 9.05 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 15.89 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 15.89 | 15809267 16690809 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 15.89 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 15.89 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 15.89 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 8.07 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 8.07 | 16752155 | |
| MESH:D014605 | Uveitis | Cyclosporine | 7.32 | 1336536 | |
| MESH:D014605 | Uveitis | Sirolimus | 7.32 | 1336536 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 6.49 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 6.49 | 16002989 16513791 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 7.44 | 17056641 | |
| MESH:D014652 | Vascular Diseases | Thalidomide | 7.44 | 15741222 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.15 | 12125929 | |
| MESH:D014657 | Vasculitis | Heparin | 4.66 | 20337814 | |
| MESH:D020301 | Vasospasm, Intracranial | fasudil | 7.86 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | pifithrin | 7.86 | 18364113 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 3.77 | 16837676 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.23 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 9.36 | 17638931 17334414 17678736 16364871 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 9.36 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 9.36 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Isoproterenol | 4.27 | 18097624 | |
| MESH:D015837 | Vestibular Diseases | Gentamicins | 4.14 | 18776599 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.70 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 6.80 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 6.80 | 11897121 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 4.11 | 16343187 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.81 | 15886252 | |
| MESH:D015430 | Weight Gain | Clozapine | 6.13 | 20521320 20107430 17502770 16141801 20564506 16402076 | |
| MESH:D015430 | Weight Gain | olanzapine | 6.13 | 19434072 17933447 20107430 | |
| MESH:D015431 | Weight Loss | Clozapine | 3.66 | 17933447 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.69 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Drugs, Chinese Herbal | 7.64 | 16313111 | |
| MESH:D014947 | Wounds and Injuries | lysophosphatidic acid | 7.64 | 15541073 | |
| MESH:D014947 | Wounds and Injuries | sphingosine 1-phosphate | 7.64 | 15541073 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 3.00 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05221 | Acute myeloid leukemia |
| KEGG:04920 | Adipocytokine signaling pathway |
| REACT:578 | Apoptosis |
| KEGG:04210 | Apoptosis |
| KEGG:04662 | B cell receptor signaling pathway |
| KEGG:04973 | Carbohydrate digestion and absorption |
| KEGG:05142 | Chagas disease (American trypanosomiasis) |
| KEGG:04062 | Chemokine signaling pathway |
| KEGG:05220 | Chronic myeloid leukemia |
| KEGG:05210 | Colorectal cancer |
| KEGG:05213 | Endometrial cancer |
| KEGG:04012 | ErbB signaling pathway |
| KEGG:04664 | Fc epsilon RI signaling pathway |
| KEGG:04666 | Fc gamma R-mediated phagocytosis |
| KEGG:04510 | Focal adhesion |
| KEGG:05214 | Glioma |
| REACT:604 | Hemostasis |
| KEGG:05160 | Hepatitis C |
| REACT:6313 | Insulin receptor mediated signaling |
| KEGG:04910 | Insulin signaling pathway |
| REACT:13552 | Integrin cell surface interactions |
| KEGG:04630 | Jak-STAT signaling pathway |
| KEGG:04010 | MAPK signaling pathway |
| KEGG:05162 | Measles |
| KEGG:05218 | Melanoma |
| REACT:12508 | Metabolism of nitric oxide |
| REACT:21257 | Metabolism of RNA |
| KEGG:04150 | mTOR signaling pathway |
| KEGG:04722 | Neurotrophin signaling pathway |
| KEGG:05223 | Non-small cell lung cancer |
| KEGG:04380 | Osteoclast differentiation |
| KEGG:05212 | Pancreatic cancer |
| KEGG:05200 | Pathways in cancer |
| KEGG:04914 | Progesterone-mediated oocyte maturation |
| KEGG:05215 | Prostate cancer |
| REACT:13698 | Regulation of beta-cell development |
| REACT:13641 | Regulation of Beta-Cell Development |
| KEGG:05211 | Renal cell carcinoma |
| REACT:14797 | Signaling by GPCR |
| REACT:6900 | Signaling in Immune system |
| REACT:11061 | Signalling by NGF |
| KEGG:05222 | Small cell lung cancer |
| KEGG:04660 | T cell receptor signaling pathway |
| KEGG:04530 | Tight junction |
| KEGG:04620 | Toll-like receptor signaling pathway |
| KEGG:05145 | Toxoplasmosis |
| KEGG:05152 | Tuberculosis |
| KEGG:04370 | VEGF signaling pathway |
| Releated gene ID | Related gene Name |
|---|---|
| PA28963 | GRB7 |
| PA29519 | HSP90AA1 |
| Releated disease ID | Related disease Name |
|---|---|
| PA446661 | Carcinoma, Small Cell |
| PA444985 | Multiple Myeloma |
| PA447216 | Schizophrenia |
| PA443622 | Carcinoma, Non-Small-Cell Lung |
| PA444750 | Leukemia |
| PA443756 | Colonic Neoplasms |
| PA445062 | Neoplasms |
| PA444818 | Lung Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA7000 | sorafenib |
| PA449167 | cyclosporine |
| PA451578 | tacrolimus |
| PA451581 | tamoxifen |
| PA451257 | risperidone |
| PA449412 | doxorubicin |
| PA131301952 | gefitinib |
| PA152241907 | lapatinib |
| PA161990676 | tetrahydrobiopterin |
| PA448547 | beclomethasone |
| PA164754818 | betamethasone |
| PA448681 | budesonide |
| PA164781399 | ciclesonide |
| PA164776996 | desonide |
| PA449247 | dexamethasone |
| PA449661 | flunisolide |
| PA449686 | fluticasone propionate |
| PA452347 | glucocorticoids |
| PA449905 | hydrocortisone |
| PA450466 | methylprednisolone |
| PA450541 | mometasone |
| PA164777035 | paramethasone |
| PA451096 | prednisolone |
| PA451100 | prednisone |
| PA164752251 | rimexolone |
| PA451749 | triamcinolone |
| PA451365 | sirolimus |
| PA449780 | glutathione |
| PA449773 | glucose |
| PA448976 | choline |
| PA152241909 | PP2 |
| PA448478 | l-arginine |
| PA164747225 | l-citrulline |
| PA450635 | nitric oxide |
| PA164744376 | adenosine monophosphate |
| PA450191 | lecithin |
| PA10804 | imatinib |
| PA164743471 | adenosine triphosphate |
| PA449014 | cisplatin |
| PA449748 | gemcitabine |
| PA448486 | arsenic trioxide |
| PA448871 | celecoxib |
| PA450626 | nicotine |
| PA452604 | xenobiotics |
| PA450970 | pioglitazone |
| PA451283 | rosiglitazone |
| PA164749238 | exenatide |
| PA165291471 | perifosine |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00171 | - | Adenosine triphosphate | Dietary supplement;Micronutrient |
| DB01169 | agonist | Arsenic trioxide | Antineoplastic Agents;Homeopathic Agents |
| DB01863 | - | Inositol 1,3,4,5-Tetrakisphosphate | |
| DB07584 | - | N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | |
| DB07585 | - | 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine |
| No data |
| No data |
| No data |